Recent advances in Lewy body dementia: A comprehensive review

Lewy Body Dementia is the second most frequent neurodegenerative illness proven to cause dementia, after Alzheimer's disease (AD). It is believed to be vastly underdiagnosed, as there is a significant disparity between the number of cases diagnosed clinically and those diagnosed via neuropathol...

Full description

Saved in:
Bibliographic Details
Published inDisease-a-month Vol. 69; no. 5; p. 101441
Main Authors Prasad, Sakshi, Katta, Maanya Rajasree, Abhishek, Shuchi, Sridhar, Rishala, Valisekka, Sai Sudha, Hameed, Maha, Kaur, Jasneet, Walia, Namrata
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.05.2023
Subjects
Online AccessGet full text
ISSN0011-5029
1557-8194
1557-8194
DOI10.1016/j.disamonth.2022.101441

Cover

Abstract Lewy Body Dementia is the second most frequent neurodegenerative illness proven to cause dementia, after Alzheimer's disease (AD). It is believed to be vastly underdiagnosed, as there is a significant disparity between the number of cases diagnosed clinically and those diagnosed via neuropathology at the time of postmortem autopsy. Strikingly, many of the pharmacologic treatments used to treat behavioral and cognitive symptoms in other forms of dementia exacerbate the symptoms of DLB. Therefore, it is critical to accurately diagnose DLB as these patients require a specific treatment approach. This article focuses on its pathophysiology, risk factors, differentials, and its diverse treatment modalities. In this study, an English language literature search was conducted on Medline, Cochrane, Embase, and Google Scholar till April 2022. The following search strings and Medical Subject Headings (MeSH) terms were used: “Lewy Body Dementia,” “Dementia with Lewy bodies,” and “Parkinson's Disease Dementia.” We explored the literature on Lewy Body Dementia for its epidemiology, pathophysiology, the role of various genes and how they bring about the disease, biomarkers, its differential diagnoses and treatment options.
AbstractList Lewy Body Dementia is the second most frequent neurodegenerative illness proven to cause dementia, after Alzheimer's disease (AD). It is believed to be vastly underdiagnosed, as there is a significant disparity between the number of cases diagnosed clinically and those diagnosed via neuropathology at the time of postmortem autopsy. Strikingly, many of the pharmacologic treatments used to treat behavioral and cognitive symptoms in other forms of dementia exacerbate the symptoms of DLB. Therefore, it is critical to accurately diagnose DLB as these patients require a specific treatment approach. This article focuses on its pathophysiology, risk factors, differentials, and its diverse treatment modalities. In this study, an English language literature search was conducted on Medline, Cochrane, Embase, and Google Scholar till April 2022. The following search strings and Medical Subject Headings (MeSH) terms were used: “Lewy Body Dementia,” “Dementia with Lewy bodies,” and “Parkinson's Disease Dementia.” We explored the literature on Lewy Body Dementia for its epidemiology, pathophysiology, the role of various genes and how they bring about the disease, biomarkers, its differential diagnoses and treatment options.
Lewy Body Dementia is the second most frequent neurodegenerative illness proven to cause dementia, after Alzheimer's disease (AD). It is believed to be vastly underdiagnosed, as there is a significant disparity between the number of cases diagnosed clinically and those diagnosed via neuropathology at the time of postmortem autopsy. Strikingly, many of the pharmacologic treatments used to treat behavioral and cognitive symptoms in other forms of dementia exacerbate the symptoms of DLB. Therefore, it is critical to accurately diagnose DLB as these patients require a specific treatment approach. This article focuses on its pathophysiology, risk factors, differentials, and its diverse treatment modalities. In this study, an English language literature search was conducted on Medline, Cochrane, Embase, and Google Scholar till April 2022. The following search strings and Medical Subject Headings (MeSH) terms were used: "Lewy Body Dementia," "Dementia with Lewy bodies," and "Parkinson's Disease Dementia." We explored the literature on Lewy Body Dementia for its epidemiology, pathophysiology, the role of various genes and how they bring about the disease, biomarkers, its differential diagnoses and treatment options.
AbstractLewy Body Dementia is the second most frequent neurodegenerative illness proven to cause dementia, after Alzheimer's disease (AD). It is believed to be vastly underdiagnosed, as there is a significant disparity between the number of cases diagnosed clinically and those diagnosed via neuropathology at the time of postmortem autopsy. Strikingly, many of the pharmacologic treatments used to treat behavioral and cognitive symptoms in other forms of dementia exacerbate the symptoms of DLB. Therefore, it is critical to accurately diagnose DLB as these patients require a specific treatment approach. This article focuses on its pathophysiology, risk factors, differentials, and its diverse treatment modalities. In this study, an English language literature search was conducted on Medline, Cochrane, Embase, and Google Scholar till April 2022. The following search strings and Medical Subject Headings (MeSH) terms were used: “Lewy Body Dementia,” “Dementia with Lewy bodies,” and “Parkinson's Disease Dementia.” We explored the literature on Lewy Body Dementia for its epidemiology, pathophysiology, the role of various genes and how they bring about the disease, biomarkers, its differential diagnoses and treatment options.
Lewy Body Dementia is the second most frequent neurodegenerative illness proven to cause dementia, after Alzheimer's disease (AD). It is believed to be vastly underdiagnosed, as there is a significant disparity between the number of cases diagnosed clinically and those diagnosed via neuropathology at the time of postmortem autopsy. Strikingly, many of the pharmacologic treatments used to treat behavioral and cognitive symptoms in other forms of dementia exacerbate the symptoms of DLB. Therefore, it is critical to accurately diagnose DLB as these patients require a specific treatment approach. This article focuses on its pathophysiology, risk factors, differentials, and its diverse treatment modalities. In this study, an English language literature search was conducted on Medline, Cochrane, Embase, and Google Scholar till April 2022. The following search strings and Medical Subject Headings (MeSH) terms were used: "Lewy Body Dementia," "Dementia with Lewy bodies," and "Parkinson's Disease Dementia." We explored the literature on Lewy Body Dementia for its epidemiology, pathophysiology, the role of various genes and how they bring about the disease, biomarkers, its differential diagnoses and treatment options.Lewy Body Dementia is the second most frequent neurodegenerative illness proven to cause dementia, after Alzheimer's disease (AD). It is believed to be vastly underdiagnosed, as there is a significant disparity between the number of cases diagnosed clinically and those diagnosed via neuropathology at the time of postmortem autopsy. Strikingly, many of the pharmacologic treatments used to treat behavioral and cognitive symptoms in other forms of dementia exacerbate the symptoms of DLB. Therefore, it is critical to accurately diagnose DLB as these patients require a specific treatment approach. This article focuses on its pathophysiology, risk factors, differentials, and its diverse treatment modalities. In this study, an English language literature search was conducted on Medline, Cochrane, Embase, and Google Scholar till April 2022. The following search strings and Medical Subject Headings (MeSH) terms were used: "Lewy Body Dementia," "Dementia with Lewy bodies," and "Parkinson's Disease Dementia." We explored the literature on Lewy Body Dementia for its epidemiology, pathophysiology, the role of various genes and how they bring about the disease, biomarkers, its differential diagnoses and treatment options.
ArticleNumber 101441
Author Sridhar, Rishala
Abhishek, Shuchi
Katta, Maanya Rajasree
Hameed, Maha
Valisekka, Sai Sudha
Walia, Namrata
Prasad, Sakshi
Kaur, Jasneet
Author_xml – sequence: 1
  givenname: Sakshi
  surname: Prasad
  fullname: Prasad, Sakshi
  email: sakshiprasad8@gmail.com
  organization: Faculty of Medicine, National Pirogov Memorial Medical University, 21018, Vinnytsya, Ukraine
– sequence: 2
  givenname: Maanya Rajasree
  surname: Katta
  fullname: Katta, Maanya Rajasree
  organization: Gandhi Medical College, Hyderabad, Telangana, India
– sequence: 3
  givenname: Shuchi
  surname: Abhishek
  fullname: Abhishek, Shuchi
  organization: Kasturba Medical College, Manipal, Karnataka, India
– sequence: 4
  givenname: Rishala
  surname: Sridhar
  fullname: Sridhar, Rishala
  organization: Guangxi Medical University, Nanning, Guangxi, China
– sequence: 5
  givenname: Sai Sudha
  surname: Valisekka
  fullname: Valisekka, Sai Sudha
  organization: Sri Venkateshwara Medical College, Tirupati, India
– sequence: 6
  givenname: Maha
  surname: Hameed
  fullname: Hameed, Maha
  organization: Alfaisal University College of Medicine, Riyadh, Saudi Arabia
– sequence: 7
  givenname: Jasneet
  surname: Kaur
  fullname: Kaur, Jasneet
  organization: Government Medical College, Amritsar, India
– sequence: 8
  givenname: Namrata
  surname: Walia
  fullname: Walia, Namrata
  organization: Department of Psychiatry and Behavioral Sciences, University of Texas Health Sciences Center, Houston, Texas, United States of America
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35690493$$D View this record in MEDLINE/PubMed
BookMark eNqNkl9v2yAUxdHUaU27fYXNj31xdiHGmErtFFX7UynSpHZ7RhiuVTIbUnBS5dsPK-0eKk3tEwLOORd-956QIx88EvKJwpwCrT-v59YlPQQ_3s0ZMDadVhV9Q2aUc1E2VFZHZAZAacmByWNyktI6b5nk8I4cL3gtoZKLGbm4QYN-LLTdaW8wFc4XK3zYF22w-8LikC-dPi-WhQnDJuId-uR2WETcOXx4T952uk_44XE9Jb-_ff119aNc_fx-fbVclYYv6FgK0UqqNe9ExZlpJGDXioppwTivwFIhjNW0bgCaBhrG6s5IlBTq7Kqsbhen5OyQu4nhfotpVINLBvteewzbpFgteA0sR2Tpx0fpth3Qqk10g4579fTlLLg4CEwMKUXslHGjHl1mGbXrFQU1IVZr9Q-xmhCrA-LsF8_8TyVedi4PTsyoMr6oknGYqVsX0YzKBveKjMtnGaZ33hnd_8E9pnXYRp87oahKTIG6nUZgmgDGpu5zyAFf_h_wqif8BSUuwx0
CitedBy_id crossref_primary_10_1177_2050313X241229058
crossref_primary_10_1007_s10787_024_01492_1
crossref_primary_10_3390_neuroglia5040030
crossref_primary_10_3390_ijms25179197
crossref_primary_10_4140_TCP_n_2024_300
crossref_primary_10_3390_ijms252212114
crossref_primary_10_1002_jcph_6103
crossref_primary_10_3390_ijms252111490
crossref_primary_10_1016_j_ncl_2024_05_005
crossref_primary_10_1038_s41514_024_00180_2
crossref_primary_10_1212_CON_0000000000001496
crossref_primary_10_3390_jcm13144202
crossref_primary_10_3390_ijms23169364
crossref_primary_10_1002_alz_14118
crossref_primary_10_47485_2693_2490_1089
crossref_primary_10_1007_s44169_024_00059_z
crossref_primary_10_1016_j_heliyon_2024_e35432
crossref_primary_10_1016_j_jagp_2024_04_005
crossref_primary_10_1016_j_ahr_2024_100194
crossref_primary_10_3389_fneur_2024_1395413
Cites_doi 10.5114/fn.2013.34190
10.1002/mds.10557
10.1371/journal.pone.0045451
10.1016/S1474-4422(10)70194-0
10.1111/ene.14032
10.1001/jamaneurol.2017.0603
10.1016/j.parkreldis.2014.12.007
10.1016/S1474-4422(09)70146-2
10.1001/jamaneurol.2013.1925
10.1186/s13195-014-0083-0
10.1007/s11065-018-9396-2
10.1016/j.jagp.2013.11.007
10.1016/j.jalz.2011.03.008
10.1002/ana.24777
10.1159/000074681
10.1001/jamaneurol.2013.600
10.1002/mds.21507
10.1212/01.WNL.0000165987.89198.65
10.1038/s41598-019-44173-8
10.1017/S1041610217002010
10.1007/s11055-008-9077-3
10.1016/j.bbapap.2019.03.001
10.1017/S1355617704105043
10.3233/JAD-2005-8307
10.1186/s13195-018-0350-6
10.1212/01.wnl.0000434309.85312.19
10.3390/biom10081177
10.1177/1533317510390351
10.4172/2161-0460.1000444
10.1155/2013/728158
10.1176/appi.ajp.2015.173501
10.1016/j.parkreldis.2010.06.004
10.1212/WNL.0000000000004058
10.1007/s11940-016-0433-2
10.3233/JAD-191153
10.1002/gps.4015
10.1017/S0033291713000494
10.1111/jnc.14965
10.1093/brain/awx243
10.1007/s11604-019-00881-9
10.1002/gps.1738
10.1007/s00415-018-8892-x
10.1093/arclin/acx085
10.1007/s00415-009-5324-y
10.1002/gps.949
10.1177/1533317519869700
10.1111/j.1532-5415.2005.53221.x
10.1016/j.redox.2017.10.014
10.5607/en.2013.22.4.249
10.1002/gps.995
10.2147/DDDT.S240865
10.1177/0891988716654984
10.1080/14656566.2018.1445721
10.1093/brain/aws126
10.1159/000333072
10.1016/S1474-4422(05)70219-2
10.1111/nan.12554
10.1001/jamaneurol.2016.4926
10.1212/01.WNL.0000125192.69777.6D
10.1016/j.parkreldis.2015.11.019
10.1159/000441184
10.1177/1533317515603359
10.1136/jnnp.2002.002576
10.1097/NRL.0b013e31827c6bdd
10.1136/jnnp-2014-307659
10.1136/eb-2017-102848
10.1007/s40520-020-01576-2
10.1093/brain/awh725
10.1007/s10072-016-2744-1
10.1002/mds.111
10.1016/j.jagp.2013.03.001
10.1016/S0924-9338(10)70986-X
10.1186/s13195-017-0331-1
10.1017/cjn.2016.2
10.1007/s11910-017-0789-z
10.1192/bjp.bp.111.095273
10.1002/gps.2277
10.1093/brain/aws234
10.1371/journal.pone.0115425
10.1111/j.1479-8301.2009.00283.x
10.1093/brain/awu193
10.1111/ene.13449
10.1176/appi.ajp.2015.14121582
10.1017/S0033291717003257
10.1345/aph.1R522
10.1016/j.brainres.2021.147481
10.1002/gps.4109
10.1016/j.jamda.2016.07.014
10.1093/fampra/cmn071
10.4088/JCP.17m11623
10.1016/j.archger.2007.03.003
10.1002/mds.27731
10.1212/WNL.0000000000010943
10.1007/s10072-015-2357-0
10.1002/gps.4609
10.1001/jamaneurol.2016.0031
10.3390/ijms20194674
10.1136/jnnp-2021-327788
10.1111/j.1755-5949.2010.00216.x
10.1007/s00401-020-02160-8
10.1212/01.wnl.0000172351.95783.8e
10.1038/nrneurol.2017.27
10.1212/01.wnl.0000187889.17253.b1
10.1186/s13195-021-00907-3
10.1007/s00702-019-02137-2
10.1001/archneur.64.3.416
10.47102/annals-acadmedsg.V36N8p707
10.1016/S1474-4422(19)30153-X
10.1016/S0010-9452(08)70489-1
10.1016/j.parkreldis.2010.03.007
10.1159/000107703
10.1097/WAD.0000000000000414
10.1002/ana.23557
10.1016/0022-3956(75)90026-6
10.1186/s13195-020-00610-9
10.1159/000351672
10.1002/gps.2506
10.1186/s40478-021-01175-w
10.1212/01.wnl.0000180964.60708.c2
10.1186/s13024-019-0329-1
10.1038/nrn3549
10.1002/mds.21956
10.1002/mds.25523
10.3233/JAD-161089
10.1016/S0140-6736(15)00462-6
10.1017/S1041610215002288
10.1186/s13195-020-00684-5
10.3390/diagnostics10121015
10.1002/ana.25824
10.1002/gps.3952
10.1186/s13195-020-00613-6
10.1016/j.cger.2018.06.007
10.1016/j.parkreldis.2019.12.005
10.1016/j.neurobiolaging.2009.05.019
10.3233/JAD-200893
10.1007/s00401-021-02367-3
10.1097/WAD.0b013e3181e6a4d7
10.3390/biom11101419
10.3389/fnagi.2021.717930
10.1007/s11910-012-0253-z
10.1001/archneur.63.10.1450
10.1159/000101512
10.1080/13854040500376831
10.4088/JCP.v66n0514
10.1111/j.1479-8301.2009.00292.x
10.1186/s13195-015-0128-z
10.1017/S0033291718003161
10.1002/gps.389
10.1177/0004867419835029
10.1186/s12916-018-1016-8
10.1007/s11065-016-9334-0
10.1186/s13195-014-0081-2
10.1212/CON.0000000000000309
10.1016/j.jagp.2021.07.002
10.1186/s13195-019-0537-5
10.3390/bs11070094
10.1136/bmjopen-2014-005158
10.1136/jnnp-2012-304381
10.1016/j.neurobiolaging.2011.10.014
10.1002/alz.12411
10.1002/mds.27355
10.1016/j.cca.2019.04.078
10.1007/s40520-013-0136-4
ContentType Journal Article
Copyright 2022 The Author(s)
The Author(s)
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2022 The Author(s)
– notice: The Author(s)
– notice: Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.disamonth.2022.101441
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1557-8194
EndPage 101441
ExternalDocumentID 35690493
10_1016_j_disamonth_2022_101441
S0011502922001250
1_s2_0_S0011502922001250
Genre Journal Article
Review
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACRLP
ACRPL
ADBBV
ADEZE
ADMUD
ADNMO
ADVLN
AEBSH
AEFWE
AEIPS
AEKER
AEVXI
AFFNX
AFJKZ
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEA
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
KOM
L7B
LZ2
M29
M41
MO0
N4W
N9A
O-L
O9-
OAUVE
OD~
OO0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SDF
SDG
SDP
SEL
SES
SEW
SJN
SPCBC
SSH
SSZ
T5K
UNMZH
WOW
WUQ
Z5R
ZGI
ZXP
~G-
AFCTW
AGRNS
RIG
6I.
AACTN
AAFTH
AAIAV
ABLVK
ABYKQ
AFKWA
AJBFU
AJOXV
AMFUW
EFLBG
LCYCR
AAYXX
CITATION
~HD
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ACLOT
ID FETCH-LOGICAL-c531t-77b91aa5f7452c890efb742a725540d177cda168008808226fc9e910691a4dab3
IEDL.DBID .~1
ISSN 0011-5029
1557-8194
IngestDate Sat Sep 27 19:53:29 EDT 2025
Mon Jul 21 06:03:24 EDT 2025
Thu Sep 18 00:23:28 EDT 2025
Thu Apr 24 23:03:07 EDT 2025
Fri Feb 23 02:36:47 EST 2024
Fri May 16 01:02:27 EDT 2025
Tue Aug 26 19:29:20 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Synucleinopathies
Parkinson disease dementia
Lewy body dementia
Dementia with Lewy bodies
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c531t-77b91aa5f7452c890efb742a725540d177cda168008808226fc9e910691a4dab3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0011502922001250
PMID 35690493
PQID 2675602168
PQPubID 23479
PageCount 1
ParticipantIDs proquest_miscellaneous_2675602168
pubmed_primary_35690493
crossref_citationtrail_10_1016_j_disamonth_2022_101441
crossref_primary_10_1016_j_disamonth_2022_101441
elsevier_sciencedirect_doi_10_1016_j_disamonth_2022_101441
elsevier_clinicalkeyesjournals_1_s2_0_S0011502922001250
elsevier_clinicalkey_doi_10_1016_j_disamonth_2022_101441
PublicationCentury 2000
PublicationDate 2023-05-01
PublicationDateYYYYMMDD 2023-05-01
PublicationDate_xml – month: 05
  year: 2023
  text: 2023-05-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Disease-a-month
PublicationTitleAlternate Dis Mon
PublicationYear 2023
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Robertson, Messner, Shirzadi (bib0054) 2016; 22
Frigerio, Fujishiro, Ahn (bib0091) 2011; 32
Hely, Reid, Adena, Halliday, Morris (bib0007) 2008; 23
Friedman (bib0163) 2018; 19
Irwin, Lee, Trojanowski (bib0032) 2013; 14
Ikeda, Mori, Matsuo, Nakagawa, Kosaka (bib0135) 2015; 7
Savica, Grossardt, Bower (bib0015) 2017; 74
Thaisetthawatkul, Boeve, Benarroch (bib0052) 2004; 62
Bargar, Wang, Gunzler (bib0073) 2021; 9
Boström, Jönsson, Minthon, Londos (bib0001) 2007; 22
van de Beek, Babapour Mofrad, van Steenoven (bib0069) 2020; 12
Mehra, Gadhe, Bera, Sawner, Maji (bib0023) 2021; 11
McKeith, Boeve, Dickson (bib0083) 2017; 89
Edwards, Royall, Hershey (bib0143) 2007; 23
Varanese, Perfetti, Gilbert-Wolf, Thomas, Onofrj, Di Rocco (bib0168) 2013; 28
Chouliaras L., Thomas A., Malpetti M., et alDifferential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsyJournal of Neurology, Neurosurgery & Psychiatry Published Online First: 25 January 2022. doi
Morrin, Fang, Servant, Aarsland, Rajkumar (bib0154) 2018; 30
Emre, Aarsland, Brown (bib0004) 2007; 22
McCarter, St Louis, Boeve (bib0048) 2012; 12
Tiraboschi, Salmon, Hansen, Hofstetter, Thal, Corey-Bloom (bib0101) 2006; 129
Nasreddine, Phillips, Bédirian (bib0115) 2005; 53
Aarsland, Ballard, Larsen, McKeith (bib0039) 2001; 16
Hamilton, Salmon, Galasko (bib0100) 2004; 10
Minett, Thomas, Wilkinson (bib0139) 2003; 18
Iftikhar, Alghothani, Trotti (bib0170) 2017; 24
Choudhury, Graff-Radford, Aakre (bib0036) 2022; 18
Tousi, Leverenz (bib0176) 2021; 15
Hasegawa, Kochi, Maruyama, Konishi, Toya, Odawara (bib0046) 2021; 79
Oda, Yamamoto, Maeda (bib0042) 2009; 9
.
Aarsland, Perry, Larsen (bib0160) 2005; 66
Murata, Odawara, Hasegawa (bib0178) 2020; 76
Gurnani, Gavett (bib0113) 2017; 27
Terzaghi, Arnaldi, Rizzetti (bib0049) 2013; 28
Canaslan, Schmitz, Villar-Piqué (bib0064) 2021; 13
Jung, St Louis (bib0172) 2016; 18
van Steenoven, van der Flier, Scheltens, Teunissen, Lemstra (bib0067) 2019; 11
van Steenoven, Majbour, Vaikath (bib0071) 2018; 33
Meade, Fairlie, Mason (bib0024) 2019; 14
Singer, Schmeichel, Shahnawaz (bib0061) 2020; 88
Soril, Leggett, Lorenzetti (bib0157) 2014; 9
Donaghy, Thomas, O'Brien (bib0092) 2013
Aarsland, Creese, Politis (bib0016) 2017; 13
Galvin, Duda, Kaufer (bib0106) 2010; 16
Stinton, McKeith, Taylor (bib0132) 2015; 172
accessed March 31, 2022
Morenas-Rodríguez, Alcolea, Suárez-Calvet (bib0079) 2019; 9
Mittal, Kurup, Williamson, Muralee, Tampi (bib0162) 2011; 26
Mori, Ikeda, Nagai, Matsuo, Nakagawa, Kosaka (bib0137) 2015; 7
Emre, Tsolaki, Bonuccelli (bib0146) 2010; 9
Parnetti, Paciotti, Farotti, Bellomo, Sepe, Eusebi (bib0058) 2019; 495
Alisky (bib0148) 2007; 36
Emre, Aarsland, Brown (bib0089) 2007; 22
Boot (bib0047) 2015; 7
Edwards, Hershey, Wray (bib0142) 2004; 17
Førland, Tysnes, Aarsland (bib0068) 2020; 27
Serý, Povová, Míšek, Pešák, Janout (bib0022) 2013; 51
Cilia, Tunesi, Marotta, Cereda, Siri (bib0093) 2016; 80
Kuring, Mathias, Ward (bib0164) 2018; 28
Folstein, Folstein, McHugh (bib0114) 1975; 12
Borroni, Agosti, Padovani (bib0057) 2008; 46
Walker, Possin, Boeve, Aarsland (bib0008) 2015; 386
AIu, Fedorova, Bel'gusheva (bib0174) 2010; 110
Culo, Mulsant, Rosen (bib0167) 2010; 24
Tsunoda, Hashimoto, Ishikawa (bib0055) 2018; 79
Vann Jones, O’Brien (bib0103) 2014; 44
Schumacher, Thomas, Peraza (bib0130) 2020; 12
Cagnin, Bussse, Gardini (bib0096) 2015; 5
Chin, Teodorczuk, Watson (bib0156) 2019; 53
Donaghy, Thomas, O'Brien (bib0098) 2015; 23
Ferman, Smith, Boeve, Graff-Radford, Lucas, Knopman (bib0094) 2006; 20
Reus, Fochtmann, Eyler (bib0159) 2016; 173
Hogan, Fiest, Roberts (bib0013) 2016; 43
Metzler-Baddeley (bib0117) 2007; 43
Kurzawa-Akanbi, Tammireddy, Fabrik (bib0074) 2021; 142
Auning, Rongve, Fladby (bib0085) 2011; 32
Odawara, Hasegawa, Kajiwara (bib0177) 2022; 30
Van Dyk, Towns, Tatarina (bib0041) 2016; 31
Ikeda, Mori, Kosaka (bib0136) 2013; 36
Jellinger, Korczyn (bib0037) 2018; 16
McKeith, Cummings (bib0050) 2005; 4
McKeith, Dickson, Lowe (bib0090) 2005; 65
Thomas, Taylor, McKeith (bib0105) 2017; 32
Mavroudis, Petridis, Kazis (bib0066) 2019; 34
Bohnen, Müller, Frey (bib0126) 2017; 17
Milán-Tomás, Fernández-Matarrubia, Rodríguez-Oroz (bib0040) 2021; 11
Litvinenko, Odinak, Mogil'naya, Emelin (bib0141) 2008; 38
Gomperts (bib0026) 2016; 22
NICE. Dementia: assessment, management and support for people living with dementia and their carers. 2018.
Nalls, Duran, Lopez (bib0010) 2013; 70
Cagnin, Busse, Gardini (bib0120) 2015; 5
Eversfield, Orton (bib0056) 2019; 49
Yoshizawa, Vonsattel, Honig (bib0118) 2013; 84
Caviness, Lue, Adler, Walker (bib0025) 2011; 17
Kraybill, Larson, Tsuang (bib0112) 2005; 64
Mathuranath, Nestor, Berrios, Rakowicz, Hodges (bib0116) 2000; 55
Johnson, Morris, Galvin (bib0044) 2005; 65
Wang, Yu, Tang (bib0133) 2015; 86
Hall, Reyes, Landeck (bib0031) 2014; 137
Graff-Radford, Aakre, Savica (bib0018) 2017; 74
Ferreira (bib0059) 2020; vol. 95
Lucetti, Logi, Del Dotto (bib0173) 2010; 16
McKeith, Boeve, Dickson (bib0003) 2017; 89
Matsunaga, Kishi, Iwata (bib0152) 2015; 23
Sanford (bib0012) 2018; 34
Katayama, Sawada, Takahashi, Yahara, Hasebe (bib0076) 2021; 13
McCann, Aarsland, Ueland, Solvang, Nordrehaug, Giil (bib0081) 2021; 1765
Aarsland, Ballard, Walker (bib0144) 2009; 8
Bousiges, Philippi, Lavaux (bib0070) 2020; 12
Surendranathan, O'Brien (bib0123) 2018; 21
Lerche, Machetanz, Wurster (bib0075) 2019; 34
Zhang, Sun, Wang, Tang, Xie (bib0171) 2017; 38
Jellinger (bib0002) 2003; 18
Palmqvist, Hansson, Minthon, Londos (bib0011) 2009; 24
Stubendorff, Aarsland, Minthon, Londos (bib0053) 2012; 7
Vann Jones, O'Brien (bib0084) 2014; 44
Cheignon, Tomas, Bonnefont-Rousselot, Faller, Hureau, Collin (bib0020) 2018; 14
Nelson, Jicha, Kryscio (bib0107) 2010; 257
Breitve (bib0119) 2014; 6
Rossi, Candelise, Baiardi (bib0072) 2020; 140
Yousaf, Dervenoulas, Valkimadi, Politis (bib0128) 2019; 266
Takahashi, Mizukami, Yasuno, Asada (bib0169) 2009; 9
Bejanin, Schonhaut, La Joie (bib0111) 2017; 140
Mori, Ikeda, Kosaka (bib0134) 2012; 72
Jellinger, Wenning, Seppi (bib0017) 2007; 4
Lopez, Kuller, Becker (bib0109) 2007; 64
Larsson, Aarsland, Ballard, Minthon, Londos (bib0151) 2010; 25
Armstrong, Irwin, Leverenz, Gamez, Taylor, Galvin (bib0060) 2021; 35
Pao, Boeve, Ferman (bib0127) 2013; 19
Rongve, Vossius, Nore, Testad, Aarsland (bib0158) 2014; 29
Kostopoulou, Delaney, Munro (bib0104) 2008; 6
Fields (bib0038) 2017; 32
Kane, Surendranathan, Bentley (bib0006) 2018; 10
Abu-Rumeileh, Capellari, Stanzani-Maserati (bib0062) 2018; 10
Meagher, Adamis, Trzepacz (bib0086) 2012; 200
Fanciulli, Assogna, Caltagirone, Spalletta, Pontieri (bib0175) 2013; 25
Schneider, Arvanitakis, Yu, Boyle, Leurgans, Bennett (bib0110) 2012; 135
Ishii (bib0124) 2020; 38
Romo-Gutiérrez, Yescas, López-López, Boll (bib0009) 2015; 151
Uchiyama, Nishio, Yokoi (bib0045) 2012; 135
Watson, Colloby (bib0125) 2016; 29
Auning, Rongve, Fladby (bib0035) 2011; 32
Chatzikonstantinou, McKenna, Karantali, Petridis, Kazis, Mavroudis (bib0129) 2021; 33
Albert, DeKosky, Dickson (bib0108) 2011; 7
Tsuang, Leverenz, Lopez (bib0030) 2013; 70
Watts, Storr, Barr, Rajkumar (bib0131) 2022
Vasile, Vasiliu, Vasile (bib0165) 2010; 25
Mathys, McCarrell, Sleeper (bib0147) 2013; 47
Baskys (bib0051) 2004; 65
Sadiq, Whitfield, Lee, Stevens, Costafreda, Walker (bib0097) 2017; 58
Zhang, Chen, Su (bib0043) 2016; 37
Stavitsky, Brickman, Scarmeas (bib0102) 2006; 63
Meeus, Verstraeten, Crosiers (bib0029) 2012; 33
Caffarra, Gardini, Dieci (bib0121) 2013; 27
Ridha, Josephs, Rossor (bib0150) 2005; 65
Bradshaw, Saling, Hopwood, Anderson, Brodtmann (bib0095) 2004; 75
Mehra, Sahay, Maji (bib0021) 2019; 1867
Weintraub, Chiang, Kim (bib0161) 2016; 73
Brás, Dominguez-Meijide, Gerhardt (bib0027) 2020; 153
Hyun, Yoon, Lee, Lee (bib0028) 2013; 22
Stubendorff, Larsson, Ballard, Minthon, Aarsland, Londos (bib0153) 2014; 4
Connors, Quinto, McKeith (bib0155) 2018; 48
Cagnin, Busse, Jelcic (bib0122) 2015; 21
Menendez-Gonzalez, Calatayud (bib0149) 2005; 8
Marder (bib0014) 2010; 25
Taylor, McKeith, Burn (bib0019) 2020; 19
Chatterjee, van Steenoven, Huisman (bib0063) 2020; 10
Wesnes, Aarsland, Ballard, Londos (bib0145) 2015; 30
van Steenoven, Noli, Cocco (bib0078) 2019; 20
Bellomo, Paolini Paoletti, Chipi (bib0065) 2020; 10
Irwin, Hurtig (bib0099) 2018; 8
Gmitterova, Varges, Schmitz (bib0077) 2020; 73
Vann Jones, O'Brien (bib0005) 2014; 44
Siderowf, Aarsland, Mollenhauer, Goldman, Ravina (bib0034) 2018; 33
Aarsland, Hutchinson, Larsen (bib0140) 2003; 18
Hansen, Ling, Lashley, Holton, Warner (bib0033) 2019; 45
Bougea, Stefanis, Emmanouilidou, Vekrelis, Kapaki (bib0082) 2020; 127
Richardson, Teodorczuk, Bellelli (bib0088) 2016; 28
Morandi, Davis, Bellelli (bib0087) 2017; 18
van Steenoven (10.1016/j.disamonth.2022.101441_bib0078) 2019; 20
Frigerio (10.1016/j.disamonth.2022.101441_bib0091) 2011; 32
Matsunaga (10.1016/j.disamonth.2022.101441_bib0152) 2015; 23
Schneider (10.1016/j.disamonth.2022.101441_bib0110) 2012; 135
Minett (10.1016/j.disamonth.2022.101441_bib0139) 2003; 18
Bargar (10.1016/j.disamonth.2022.101441_bib0073) 2021; 9
Ferman (10.1016/j.disamonth.2022.101441_bib0094) 2006; 20
Zhang (10.1016/j.disamonth.2022.101441_bib0171) 2017; 38
Soril (10.1016/j.disamonth.2022.101441_bib0157) 2014; 9
van de Beek (10.1016/j.disamonth.2022.101441_bib0069) 2020; 12
Hely (10.1016/j.disamonth.2022.101441_bib0007) 2008; 23
Boot (10.1016/j.disamonth.2022.101441_bib0047) 2015; 7
Thaisetthawatkul (10.1016/j.disamonth.2022.101441_bib0052) 2004; 62
Brás (10.1016/j.disamonth.2022.101441_bib0027) 2020; 153
Nasreddine (10.1016/j.disamonth.2022.101441_bib0115) 2005; 53
Irwin (10.1016/j.disamonth.2022.101441_bib0099) 2018; 8
Terzaghi (10.1016/j.disamonth.2022.101441_bib0049) 2013; 28
Tsunoda (10.1016/j.disamonth.2022.101441_bib0055) 2018; 79
Serý (10.1016/j.disamonth.2022.101441_bib0022) 2013; 51
Aarsland (10.1016/j.disamonth.2022.101441_bib0140) 2003; 18
Singer (10.1016/j.disamonth.2022.101441_bib0061) 2020; 88
Ikeda (10.1016/j.disamonth.2022.101441_bib0135) 2015; 7
Cilia (10.1016/j.disamonth.2022.101441_bib0093) 2016; 80
Kurzawa-Akanbi (10.1016/j.disamonth.2022.101441_bib0074) 2021; 142
Kostopoulou (10.1016/j.disamonth.2022.101441_bib0104) 2008; 6
Robertson (10.1016/j.disamonth.2022.101441_bib0054) 2016; 22
Lopez (10.1016/j.disamonth.2022.101441_bib0109) 2007; 64
Thomas (10.1016/j.disamonth.2022.101441_bib0105) 2017; 32
Mittal (10.1016/j.disamonth.2022.101441_bib0162) 2011; 26
McKeith (10.1016/j.disamonth.2022.101441_bib0090) 2005; 65
Aarsland (10.1016/j.disamonth.2022.101441_bib0160) 2005; 66
Yousaf (10.1016/j.disamonth.2022.101441_bib0128) 2019; 266
Baskys (10.1016/j.disamonth.2022.101441_bib0051) 2004; 65
Emre (10.1016/j.disamonth.2022.101441_bib0089) 2007; 22
Bellomo (10.1016/j.disamonth.2022.101441_bib0065) 2020; 10
Førland (10.1016/j.disamonth.2022.101441_bib0068) 2020; 27
Marder (10.1016/j.disamonth.2022.101441_bib0014) 2010; 25
Tiraboschi (10.1016/j.disamonth.2022.101441_bib0101) 2006; 129
Vann Jones (10.1016/j.disamonth.2022.101441_bib0084) 2014; 44
Stavitsky (10.1016/j.disamonth.2022.101441_bib0102) 2006; 63
Surendranathan (10.1016/j.disamonth.2022.101441_bib0123) 2018; 21
Edwards (10.1016/j.disamonth.2022.101441_bib0142) 2004; 17
Mehra (10.1016/j.disamonth.2022.101441_bib0021) 2019; 1867
Walker (10.1016/j.disamonth.2022.101441_bib0008) 2015; 386
Romo-Gutiérrez (10.1016/j.disamonth.2022.101441_bib0009) 2015; 151
Ishii (10.1016/j.disamonth.2022.101441_bib0124) 2020; 38
Stubendorff (10.1016/j.disamonth.2022.101441_bib0053) 2012; 7
Parnetti (10.1016/j.disamonth.2022.101441_bib0058) 2019; 495
Hyun (10.1016/j.disamonth.2022.101441_bib0028) 2013; 22
Johnson (10.1016/j.disamonth.2022.101441_bib0044) 2005; 65
Galvin (10.1016/j.disamonth.2022.101441_bib0106) 2010; 16
Vann Jones (10.1016/j.disamonth.2022.101441_bib0005) 2014; 44
McKeith (10.1016/j.disamonth.2022.101441_bib0083) 2017; 89
Mori (10.1016/j.disamonth.2022.101441_bib0134) 2012; 72
Jellinger (10.1016/j.disamonth.2022.101441_bib0002) 2003; 18
Mori (10.1016/j.disamonth.2022.101441_bib0137) 2015; 7
Rossi (10.1016/j.disamonth.2022.101441_bib0072) 2020; 140
Pao (10.1016/j.disamonth.2022.101441_bib0127) 2013; 19
Choudhury (10.1016/j.disamonth.2022.101441_bib0036) 2022; 18
Caviness (10.1016/j.disamonth.2022.101441_bib0025) 2011; 17
Mathys (10.1016/j.disamonth.2022.101441_bib0147) 2013; 47
Bradshaw (10.1016/j.disamonth.2022.101441_bib0095) 2004; 75
Tsuang (10.1016/j.disamonth.2022.101441_bib0030) 2013; 70
Hamilton (10.1016/j.disamonth.2022.101441_bib0100) 2004; 10
Bougea (10.1016/j.disamonth.2022.101441_bib0082) 2020; 127
Fanciulli (10.1016/j.disamonth.2022.101441_bib0175) 2013; 25
Richardson (10.1016/j.disamonth.2022.101441_bib0088) 2016; 28
10.1016/j.disamonth.2022.101441_bib0080
Watts (10.1016/j.disamonth.2022.101441_bib0131) 2022
Connors (10.1016/j.disamonth.2022.101441_bib0155) 2018; 48
Bejanin (10.1016/j.disamonth.2022.101441_bib0111) 2017; 140
Kuring (10.1016/j.disamonth.2022.101441_bib0164) 2018; 28
Abu-Rumeileh (10.1016/j.disamonth.2022.101441_bib0062) 2018; 10
McCann (10.1016/j.disamonth.2022.101441_bib0081) 2021; 1765
Meade (10.1016/j.disamonth.2022.101441_bib0024) 2019; 14
Meeus (10.1016/j.disamonth.2022.101441_bib0029) 2012; 33
Friedman (10.1016/j.disamonth.2022.101441_bib0163) 2018; 19
AIu (10.1016/j.disamonth.2022.101441_bib0174) 2010; 110
Aarsland (10.1016/j.disamonth.2022.101441_bib0039) 2001; 16
Bohnen (10.1016/j.disamonth.2022.101441_bib0126) 2017; 17
Jellinger (10.1016/j.disamonth.2022.101441_bib0017) 2007; 4
10.1016/j.disamonth.2022.101441_bib0138
Tousi (10.1016/j.disamonth.2022.101441_bib0176) 2021; 15
Chin (10.1016/j.disamonth.2022.101441_bib0156) 2019; 53
Albert (10.1016/j.disamonth.2022.101441_bib0108) 2011; 7
Uchiyama (10.1016/j.disamonth.2022.101441_bib0045) 2012; 135
Reus (10.1016/j.disamonth.2022.101441_bib0159) 2016; 173
Lerche (10.1016/j.disamonth.2022.101441_bib0075) 2019; 34
Donaghy (10.1016/j.disamonth.2022.101441_bib0098) 2015; 23
Mehra (10.1016/j.disamonth.2022.101441_bib0023) 2021; 11
Eversfield (10.1016/j.disamonth.2022.101441_bib0056) 2019; 49
Vann Jones (10.1016/j.disamonth.2022.101441_bib0103) 2014; 44
Ferreira (10.1016/j.disamonth.2022.101441_bib0059) 2020; vol. 95
Schumacher (10.1016/j.disamonth.2022.101441_bib0130) 2020; 12
Jung (10.1016/j.disamonth.2022.101441_bib0172) 2016; 18
Fields (10.1016/j.disamonth.2022.101441_bib0038) 2017; 32
Morrin (10.1016/j.disamonth.2022.101441_bib0154) 2018; 30
Auning (10.1016/j.disamonth.2022.101441_bib0085) 2011; 32
Alisky (10.1016/j.disamonth.2022.101441_bib0148) 2007; 36
Watson (10.1016/j.disamonth.2022.101441_bib0125) 2016; 29
Lucetti (10.1016/j.disamonth.2022.101441_bib0173) 2010; 16
Wesnes (10.1016/j.disamonth.2022.101441_bib0145) 2015; 30
Van Dyk (10.1016/j.disamonth.2022.101441_bib0041) 2016; 31
Litvinenko (10.1016/j.disamonth.2022.101441_bib0141) 2008; 38
McCarter (10.1016/j.disamonth.2022.101441_bib0048) 2012; 12
Vasile (10.1016/j.disamonth.2022.101441_bib0165) 2010; 25
Armstrong (10.1016/j.disamonth.2022.101441_bib0060) 2021; 35
Aarsland (10.1016/j.disamonth.2022.101441_bib0144) 2009; 8
Kane (10.1016/j.disamonth.2022.101441_bib0006) 2018; 10
Gurnani (10.1016/j.disamonth.2022.101441_bib0113) 2017; 27
van Steenoven (10.1016/j.disamonth.2022.101441_bib0067) 2019; 11
McKeith (10.1016/j.disamonth.2022.101441_bib0003) 2017; 89
Larsson (10.1016/j.disamonth.2022.101441_bib0151) 2010; 25
Culo (10.1016/j.disamonth.2022.101441_bib0167) 2010; 24
Chatzikonstantinou (10.1016/j.disamonth.2022.101441_bib0129) 2021; 33
Emre (10.1016/j.disamonth.2022.101441_bib0146) 2010; 9
Stinton (10.1016/j.disamonth.2022.101441_bib0132) 2015; 172
Hasegawa (10.1016/j.disamonth.2022.101441_bib0046) 2021; 79
Menendez-Gonzalez (10.1016/j.disamonth.2022.101441_bib0149) 2005; 8
Cagnin (10.1016/j.disamonth.2022.101441_bib0096) 2015; 5
Graff-Radford (10.1016/j.disamonth.2022.101441_bib0018) 2017; 74
McKeith (10.1016/j.disamonth.2022.101441_bib0050) 2005; 4
Wang (10.1016/j.disamonth.2022.101441_bib0133) 2015; 86
Palmqvist (10.1016/j.disamonth.2022.101441_bib0011) 2009; 24
Edwards (10.1016/j.disamonth.2022.101441_bib0143) 2007; 23
Metzler-Baddeley (10.1016/j.disamonth.2022.101441_bib0117) 2007; 43
Weintraub (10.1016/j.disamonth.2022.101441_bib0161) 2016; 73
Hall (10.1016/j.disamonth.2022.101441_bib0031) 2014; 137
Rongve (10.1016/j.disamonth.2022.101441_bib0158) 2014; 29
Katayama (10.1016/j.disamonth.2022.101441_bib0076) 2021; 13
Cheignon (10.1016/j.disamonth.2022.101441_bib0020) 2018; 14
Odawara (10.1016/j.disamonth.2022.101441_bib0177) 2022; 30
Takahashi (10.1016/j.disamonth.2022.101441_bib0169) 2009; 9
Irwin (10.1016/j.disamonth.2022.101441_bib0032) 2013; 14
Zhang (10.1016/j.disamonth.2022.101441_bib0043) 2016; 37
Cagnin (10.1016/j.disamonth.2022.101441_bib0120) 2015; 5
Sanford (10.1016/j.disamonth.2022.101441_bib0012) 2018; 34
Hansen (10.1016/j.disamonth.2022.101441_bib0033) 2019; 45
Ridha (10.1016/j.disamonth.2022.101441_bib0150) 2005; 65
Bousiges (10.1016/j.disamonth.2022.101441_bib0070) 2020; 12
Varanese (10.1016/j.disamonth.2022.101441_bib0168) 2013; 28
Jellinger (10.1016/j.disamonth.2022.101441_bib0037) 2018; 16
Stubendorff (10.1016/j.disamonth.2022.101441_bib0153) 2014; 4
Savica (10.1016/j.disamonth.2022.101441_bib0015) 2017; 74
Mathuranath (10.1016/j.disamonth.2022.101441_bib0116) 2000; 55
Morandi (10.1016/j.disamonth.2022.101441_bib0087) 2017; 18
Breitve (10.1016/j.disamonth.2022.101441_bib0119) 2014; 6
Folstein (10.1016/j.disamonth.2022.101441_bib0114) 1975; 12
Nalls (10.1016/j.disamonth.2022.101441_bib0010) 2013; 70
Taylor (10.1016/j.disamonth.2022.101441_bib0019) 2020; 19
Gmitterova (10.1016/j.disamonth.2022.101441_bib0077) 2020; 73
Sadiq (10.1016/j.disamonth.2022.101441_bib0097) 2017; 58
Yoshizawa (10.1016/j.disamonth.2022.101441_bib0118) 2013; 84
Emre (10.1016/j.disamonth.2022.101441_bib0004) 2007; 22
Siderowf (10.1016/j.disamonth.2022.101441_bib0034) 2018; 33
Hogan (10.1016/j.disamonth.2022.101441_bib0013) 2016; 43
Cagnin (10.1016/j.disamonth.2022.101441_bib0122) 2015; 21
Aarsland (10.1016/j.disamonth.2022.101441_bib0016) 2017; 13
Gomperts (10.1016/j.disamonth.2022.101441_bib0026) 2016; 22
Canaslan (10.1016/j.disamonth.2022.101441_bib0064) 2021; 13
van Steenoven (10.1016/j.disamonth.2022.101441_bib0071) 2018; 33
Oda (10.1016/j.disamonth.2022.101441_bib0042) 2009; 9
Caffarra (10.1016/j.disamonth.2022.101441_bib0121) 2013; 27
Murata (10.1016/j.disamonth.2022.101441_bib0178) 2020; 76
Meagher (10.1016/j.disamonth.2022.101441_bib0086) 2012; 200
Boström (10.1016/j.disamonth.2022.101441_bib0001) 2007; 22
Borroni (10.1016/j.disamonth.2022.101441_bib0057) 2008; 46
Iftikhar (10.1016/j.disamonth.2022.101441_bib0170) 2017; 24
Mavroudis (10.1016/j.disamonth.2022.101441_bib0066) 2019; 34
Chatterjee (10.1016/j.disamonth.2022.101441_bib0063) 2020; 10
Donaghy (10.1016/j.disamonth.2022.101441_bib0092) 2013
Nelson (10.1016/j.disamonth.2022.101441_bib0107) 2010; 257
Aun
References_xml – volume: 18
  start-page: 12
  year: 2017
  end-page: 18
  ident: bib0087
  article-title: The diagnosis of delirium superimposed on dementia: an emerging challenge
  publication-title: J Am Med Dir Assoc
– volume: 19
  start-page: 1
  year: 2013
  end-page: 6
  ident: bib0127
  article-title: Polysomnographic findings in dementia with Lewy bodies
  publication-title: Neurologist
– volume: 9
  start-page: 969
  year: 2010
  end-page: 977
  ident: bib0146
  article-title: Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
  publication-title: Lancet Neurol
– volume: 19
  start-page: 499
  year: 2018
  end-page: 505
  ident: bib0163
  article-title: Pharmacological interventions for psychosis in Parkinson's disease patients
  publication-title: Expert Opin Pharmacother
– volume: 12
  start-page: 189
  year: 1975
  end-page: 198
  ident: bib0114
  article-title: "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician
  publication-title: J Psychiatr Res
– volume: 45
  start-page: 635
  year: 2019
  end-page: 654
  ident: bib0033
  article-title: Review: clinical, neuropathological and genetic features of Lewy body dementias
  publication-title: Neuropathol Appl Neurobiol
– volume: 12
  start-page: 182
  year: 2012
  end-page: 192
  ident: bib0048
  article-title: REM sleep behavior disorder and REM sleep without atonia as an early manifestation of degenerative neurological disease [published correction appears in Curr Neurol Neurosci Rep. 2012 Apr;12(2):226]
  publication-title: Curr Neurol Neurosci Rep
– volume: 10
  start-page: 689
  year: 2004
  end-page: 697
  ident: bib0100
  article-title: A comparison of episodic memory deficits in neuropathologically-confirmed Dementia with Lewy bodies and Alzheimer's disease
  publication-title: J Int Neuropsychol Soc
– volume: 495
  start-page: 318
  year: 2019
  end-page: 325
  ident: bib0058
  article-title: Parkinson's and Lewy body dementia CSF biomarkers
  publication-title: Clin Chim Acta
– volume: 43
  start-page: 583
  year: 2007
  end-page: 600
  ident: bib0117
  article-title: A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer's disease and Parkinson's disease with dementia
  publication-title: Cortex
– volume: 48
  start-page: 1749
  year: 2018
  end-page: 1758
  ident: bib0155
  article-title: Non-pharmacological interventions for Lewy body dementia: a systematic review
  publication-title: Psychol Med
– volume: 22
  start-page: 713
  year: 2007
  end-page: 719
  ident: bib0001
  article-title: Patients with Lewy body dementia use more resources than those with Alzheimer's disease
  publication-title: Int J Geriatr Psychiatry
– volume: 89
  start-page: 88
  year: 2017
  end-page: 100
  ident: bib0083
  article-title: Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium
  publication-title: Neurology
– volume: 65
  start-page: 16
  year: 2004
  end-page: 22
  ident: bib0051
  article-title: Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms
  publication-title: J Clin Psychiatry
– volume: 44
  start-page: 673
  year: 2014
  end-page: 683
  ident: bib0103
  article-title: The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies
  publication-title: Psychol Med
– reference: Chouliaras L., Thomas A., Malpetti M., et alDifferential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsyJournal of Neurology, Neurosurgery & Psychiatry Published Online First: 25 January 2022. doi:
– volume: 27
  start-page: 1
  year: 2017
  end-page: 17
  ident: bib0113
  article-title: The Differential Effects of Alzheimer's Disease and Lewy Body Pathology on Cognitive Performance: a Meta-analysis
  publication-title: Neuropsychol Rev
– volume: 35
  start-page: 55
  year: 2021
  end-page: 61
  ident: bib0060
  article-title: Biomarker use for dementia with Lewy body diagnosis: survey of US experts
  publication-title: Alzheimer Dis Assoc Disord
– volume: 5
  start-page: 442
  year: 2015
  end-page: 449
  ident: bib0120
  article-title: Clinical and cognitive phenotype of mild cognitive impairment evolving to dementia with Lewy Bodies
  publication-title: Dement Geriatr Cogn Disord
– volume: 6
  start-page: 53
  year: 2014
  ident: bib0119
  article-title: A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer's disease
  publication-title: Alzheimers Res Ther
– volume: 30
  start-page: 46
  year: 2015
  end-page: 54
  ident: bib0145
  article-title: Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies
  publication-title: Int J Geriatr Psychiatry
– volume: 10
  start-page: 1177
  year: 2020
  ident: bib0063
  article-title: Contactin-1 is reduced in cerebrospinal fluid of Parkinson’s disease patients and is present within Lewy bodies
  publication-title: Biomolecules
– volume: 33
  start-page: 629
  year: 2012
  ident: bib0029
  article-title: DLB and PDD: a role for mutations in dementia and Parkinson disease genes?
  publication-title: Neurobiol Aging
– volume: 4
  year: 2014
  ident: bib0153
  article-title: Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson’s disease with dementia: a prospective study
  publication-title: BMJ Open
– volume: 79
  start-page: 627
  year: 2021
  end-page: 637
  ident: bib0046
  article-title: Efficacy and safety of zonisamide in dementia with Lewy bodies patients with Parkinsonism: a post hoc analysis of two randomized, double-blind, placebo-controlled trials
  publication-title: J Alzheimers Dis
– volume: 21
  start-page: 61
  year: 2018
  end-page: 65
  ident: bib0123
  article-title: Clinical imaging in dementia with Lewy bodies
  publication-title: Evid Based Ment Health
– volume: 31
  start-page: 137
  year: 2016
  end-page: 143
  ident: bib0041
  article-title: Assessing fluctuating cognition in dementia diagnosis: interrater reliability of the clinician assessment of fluctuation
  publication-title: Am J Alzheimers Dis Other Demen
– volume: 64
  start-page: 416
  year: 2007
  end-page: 420
  ident: bib0109
  article-title: Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study
  publication-title: Arch Neurol
– volume: 110
  start-page: 24
  year: 2010
  end-page: 30
  ident: bib0174
  publication-title: Zh Nevrol Psikhiatr Im S S Korsakova
– volume: 75
  start-page: 382
  year: 2004
  end-page: 387
  ident: bib0095
  article-title: Fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease is qualitatively distinct
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 32
  start-page: 1280
  year: 2017
  end-page: 1304
  ident: bib0105
  article-title: Development of assessment toolkits for improving the diagnosis of the Lewy body dementias: feasibility study within the DIAMOND Lewy study
  publication-title: Int J Geriatr Psychiatry
– volume: 23
  start-page: 401
  year: 2007
  end-page: 405
  ident: bib0143
  article-title: Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study
  publication-title: Dement Geriatr Cogn Disord
– volume: 33
  start-page: 528
  year: 2018
  end-page: 536
  ident: bib0034
  article-title: Biomarkers for cognitive impairment in Lewy body disorders: status and relevance for clinical trials
  publication-title: Mov Disord
– volume: 17
  start-page: 40
  year: 2004
  end-page: 48
  ident: bib0142
  article-title: Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 12-week interim analysis
  publication-title: Dement Geriatr Cogn Disord
– volume: 151
  start-page: 110
  year: 2015
  end-page: 118
  ident: bib0009
  article-title: Factores genéticos de la demencia en la enfermedad de Parkinson (EP) [Genetic factors associated with dementia in Parkinson's disease (PD)]
  publication-title: Gac Med Mex
– volume: 14
  start-page: 626
  year: 2013
  end-page: 636
  ident: bib0032
  article-title: Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
  publication-title: Nat Rev Neurosci
– volume: 1765
  year: 2021
  ident: bib0081
  article-title: Serum tyrosine is associated with better cognition in Lewy body dementia
  publication-title: Brain Res
– volume: 10
  start-page: 3
  year: 2018
  ident: bib0062
  article-title: The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias
  publication-title: Alzheimers Res Ther
– volume: 7
  start-page: e45451
  year: 2012
  ident: bib0053
  article-title: The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson’s disease with dementia
  publication-title: PLoS ONE
– volume: 24
  start-page: 1446
  year: 2017
  end-page: 1456
  ident: bib0170
  article-title: Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis
  publication-title: Eur J Neurol
– volume: 4
  start-page: 428
  year: 2007
  end-page: 430
  ident: bib0017
  article-title: Predictors of survival in dementia with Lewy bodies and Parkinson dementia
  publication-title: Neurodegener Dis
– volume: 28
  start-page: 1416
  year: 2013
  end-page: 1423
  ident: bib0049
  article-title: Analysis of video-polysomnographic sleep findings in dementia with Lewy bodies
  publication-title: Mov Disord
– volume: 200
  start-page: 37
  year: 2012
  end-page: 44
  ident: bib0086
  article-title: Features of subsyndromal and persistent delirium
  publication-title: The British Journal of Psychiatry
– volume: 47
  start-page: e10
  year: 2013
  ident: bib0147
  article-title: Blaszczyk AT. Visual hallucinations treated with the reinitiation of memantine in a patient with Lewy body dementia
  publication-title: Ann Pharmacother
– volume: 4
  start-page: 735
  year: 2005
  end-page: 742
  ident: bib0050
  article-title: Behavioural changes and psychological symptoms in dementia disorders
  publication-title: Lancet Neurol
– start-page: 1
  year: 2022
  end-page: 14
  ident: bib0131
  article-title: Systematic review of pharmacological interventions for people with Lewy body dementia [published online ahead of print, 2022 Feb 2]
  publication-title: Aging Ment Health
– volume: 32
  start-page: 857
  year: 2011
  end-page: 863
  ident: bib0091
  article-title: Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?
  publication-title: Neurobiol Aging
– volume: 17
  start-page: 32
  year: 2011
  end-page: 44
  ident: bib0025
  article-title: Parkinson's disease dementia and potential therapeutic strategies
  publication-title: CNS Neurosci Ther
– volume: 62
  start-page: 1804
  year: 2004
  end-page: 1809
  ident: bib0052
  article-title: Autonomic dysfunction in dementia with Lewy bodies
  publication-title: Neurology
– volume: 266
  start-page: 1
  year: 2019
  end-page: 26
  ident: bib0128
  article-title: Neuroimaging in Lewy body dementia
  publication-title: J Neurol
– volume: 37
  start-page: 57
  year: 2016
  end-page: 65
  ident: bib0043
  article-title: Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials
  publication-title: Neurol Sci
– volume: 34
  start-page: 1069
  year: 2019
  end-page: 1073
  ident: bib0075
  article-title: Dementia with Lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile
  publication-title: Mov Disord
– volume: 63
  start-page: 1450
  year: 2006
  end-page: 1456
  ident: bib0102
  article-title: The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease
  publication-title: Arch Neurol
– volume: 15
  start-page: 1811
  year: 2021
  end-page: 1817
  ident: bib0176
  article-title: The application of zonisamide to patients suffering from dementia with Lewy bodies: emerging clinical data
  publication-title: Drug Des Devel Ther
– volume: 17
  start-page: 73
  year: 2017
  ident: bib0126
  article-title: Molecular imaging and updated diagnostic criteria in Lewy body dementias
  publication-title: Curr Neurol Neurosci Rep
– volume: 65
  start-page: 481
  year: 2005
  end-page: 482
  ident: bib0150
  article-title: Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine
  publication-title: Neurology
– reference: NICE. Dementia: assessment, management and support for people living with dementia and their carers. 2018.
– volume: 27
  start-page: 213
  year: 2013
  end-page: 220
  ident: bib0121
  article-title: The Qualitative Scoring MMSE Pentagon Test (QSPT): a new method for differentiating dementia with Lewy Body from Alzheimer’s disease
  publication-title: Behav Neurol
– volume: 11
  start-page: 94
  year: 2021
  ident: bib0040
  article-title: Lewy body dementias: a coin with two sides?
  publication-title: Behav Sci (Basel)
– volume: 14
  start-page: 29
  year: 2019
  ident: bib0024
  article-title: Alpha-synuclein structure and Parkinson's disease - lessons and emerging principles
  publication-title: Mol Neurodegener
– volume: 86
  start-page: 135
  year: 2015
  end-page: 143
  ident: bib0133
  article-title: Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 21
  start-page: 303
  year: 2015
  end-page: 305
  ident: bib0122
  article-title: High specificity of MMSE pentagon scoring for diagnosis of prodromal dementia with Lewy bodies
  publication-title: Parkinsonism and Related Disorders
– volume: 20
  start-page: 623
  year: 2006
  end-page: 636
  ident: bib0094
  article-title: Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease
  publication-title: Clin Neuropsychol
– volume: 36
  start-page: 707
  year: 2007
  ident: bib0148
  article-title: Memantine-induced decompensation in a patient with Lewy body dementia
  publication-title: Ann Acad Med Singap
– volume: 51
  start-page: 1
  year: 2013
  end-page: 9
  ident: bib0022
  article-title: Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review
  publication-title: Folia Neuropathol
– volume: 32
  start-page: 786
  year: 2017
  end-page: 801
  ident: bib0038
  article-title: Cognitive and neuropsychiatric features in Parkinson's and Lewy Body Dementias
  publication-title: Arch Clin Neuropsychol
– volume: 88
  start-page: 503
  year: 2020
  end-page: 512
  ident: bib0061
  article-title: Alpha-synuclein oligomers and neurofilament light chain in spinal fluid differentiate multiple system atrophy from Lewy body synucleinopathies
  publication-title: Ann Neurol
– volume: 53
  start-page: 695
  year: 2005
  end-page: 699
  ident: bib0115
  article-title: The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment [published correction appears in J Am Geriatr Soc. 2019 Sep;67(9):1991]
  publication-title: J Am Geriatr Soc
– volume: 25
  start-page: 1
  year: 2010
  ident: bib0165
  article-title: P03-380-The efficacy of psychopharmacologic treatment in depressive disorder associated with Parkinson's disease dementia
  publication-title: European Psychiatry
– volume: 23
  start-page: 373
  year: 2015
  end-page: 383
  ident: bib0152
  article-title: Memantine for Lewy body disorders: systematic review and meta-analysis
  publication-title: Am J Geriatr Psychiatry
– volume: 18
  start-page: 591
  year: 2022
  end-page: 601
  ident: bib0036
  article-title: The temporal onset of the core features in dementia with Lewy bodies
  publication-title: Alzheimers Dement
– volume: 76
  start-page: 91
  year: 2020
  end-page: 97
  ident: bib0178
  article-title: Effect of zonisamide on parkinsonism in patients with dementia with Lewy bodies: a phase 3 randomized clinical trial
  publication-title: Parkinsonism Relat Disord
– volume: 70
  start-page: 727
  year: 2013
  end-page: 735
  ident: bib0010
  article-title: A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies
  publication-title: JAMA Neurol
– volume: 9
  start-page: 62
  year: 2021
  ident: bib0073
  article-title: Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies
  publication-title: Acta Neuropathol Commun
– volume: 73
  start-page: 535
  year: 2016
  end-page: 541
  ident: bib0161
  article-title: Association of antipsychotic use with mortality risk in patients with Parkinson disease
  publication-title: JAMA Neurol
– volume: 1867
  start-page: 890
  year: 2019
  end-page: 908
  ident: bib0021
  article-title: α-Synuclein misfolding and aggregation: implications in Parkinson’s disease pathogenesis
  publication-title: Biochim Biophys Acta Proteins Proteom
– volume: 89
  start-page: 88
  year: 2017
  end-page: 100
  ident: bib0003
  article-title: Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium
  publication-title: Neurology
– volume: 32
  start-page: 202
  year: 2011
  end-page: 208
  ident: bib0035
  article-title: Early and presenting symptoms of dementia with Lewy bodies
  publication-title: Dement Geriatr Cogn Disord
– volume: 12
  start-page: 46
  year: 2020
  ident: bib0130
  article-title: EEG alpha reactivity and cholinergic system integrity in Lewy body dementia and Alzheimer's disease
  publication-title: Alzheimers Res Ther
– volume: 34
  start-page: 603
  year: 2018
  end-page: 615
  ident: bib0012
  article-title: Lewy Body Dementia
  publication-title: Clin Geriatr Med
– volume: 79
  start-page: 17m11623
  year: 2018
  ident: bib0055
  article-title: Clinical features of auditory hallucinations in patients with dementia with Lewy bodies: a soundtrack of visual hallucinations
  publication-title: J Clin Psychiatry
– volume: 23
  start-page: 23
  year: 2015
  end-page: 37
  ident: bib0098
  article-title: Amyloid PET Imaging in Lewy body disorders
  publication-title: Am J Geriatr Psychiatry
– volume: 140
  start-page: 49
  year: 2020
  end-page: 62
  ident: bib0072
  article-title: Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies
  publication-title: Acta Neuropathol
– volume: 26
  start-page: 10
  year: 2011
  end-page: 28
  ident: bib0162
  article-title: Risk of cerebrovascular adverse events and death in elderly patients with dementia when treated with antipsychotic medications: a literature review of evidence
  publication-title: Am J Alzheimers Dis Other Demen
– volume: 18
  start-page: S2
  year: 2003
  end-page: S12
  ident: bib0002
  article-title: Neuropathological spectrum of synucleinopathies
  publication-title: Mov Disord
– volume: 24
  start-page: 1405
  year: 2009
  end-page: 1412
  ident: bib0011
  article-title: Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests
  publication-title: Int J Geriatr Psychiatry
– volume: 27
  start-page: 43
  year: 2020
  end-page: 50
  ident: bib0068
  article-title: The value of cerebrospinal fluid α-synuclein and the tau/α-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology
  publication-title: Eur J Neurol
– volume: 129
  start-page: 729
  year: 2006
  end-page: 735
  ident: bib0101
  article-title: What best differentiates Lewy body from Alzheimer's disease in early-stage dementia?
  publication-title: Brain
– volume: 30
  start-page: 395
  year: 2018
  end-page: 407
  ident: bib0154
  article-title: Systematic review of the efficacy of non-pharmacological interventions in people with Lewy body dementia
  publication-title: Int Psychogeriatr
– volume: 22
  start-page: 1689
  year: 2007
  end-page: 1707
  ident: bib0089
  article-title: Clinical diagnostic criteria for dementia associated with Parkinson's disease
  publication-title: Mov Disord
– volume: 38
  start-page: 163
  year: 2017
  end-page: 170
  ident: bib0171
  article-title: Prevalence of rapid eye movement sleep behavior disorder (RBD) in Parkinson's disease: a meta and meta-regression analysis
  publication-title: Neurol Sci
– volume: 29
  start-page: 254
  year: 2016
  end-page: 260
  ident: bib0125
  article-title: Imaging in dementia with Lewy bodies: an overview
  publication-title: J Geriatr Psychiatry Neurol
– volume: 135
  start-page: 3005
  year: 2012
  end-page: 3014
  ident: bib0110
  article-title: Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies
  publication-title: Brain
– volume: 33
  start-page: 1197
  year: 2021
  end-page: 1208
  ident: bib0129
  article-title: Electroencephalogram in dementia with Lewy bodies: a systematic review
  publication-title: Aging Clin Exp Res
– volume: 13
  start-page: 217
  year: 2017
  end-page: 231
  ident: bib0016
  article-title: Cognitive decline in Parkinson disease
  publication-title: Nat Rev Neurol
– volume: 7
  start-page: 45
  year: 2015
  ident: bib0047
  article-title: Comprehensive treatment of dementia with Lewy bodies
  publication-title: Alzheimers Res Ther
– volume: 74
  start-page: 839
  year: 2017
  end-page: 846
  ident: bib0015
  article-title: Survival and causes of death among people with clinically diagnosed synucleinopathies with parkinsonism: a population-based study
  publication-title: JAMA Neurol
– volume: 28
  start-page: 1095
  year: 2013
  end-page: 1097
  ident: bib0168
  article-title: Modafinil and armodafinil improve attention and global mental status in Lewy bodies disorders: preliminary evidence
  publication-title: Int J Geriatr Psychiatry
– volume: 25
  start-page: 601
  year: 2013
  end-page: 603
  ident: bib0175
  article-title: Rotigotine for anxiety during wearing-off in Parkinson's disease with dementia
  publication-title: Aging Clin Exp Res
– volume: 22
  start-page: 435
  year: 2016
  end-page: 463
  ident: bib0026
  article-title: Lewy Body dementias: dementia With Lewy bodies and Parkinson disease dementia
  publication-title: Continuum (Minneap Minn)
– volume: 20
  start-page: 4674
  year: 2019
  ident: bib0078
  article-title: VGF Peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
  publication-title: Int J Mol Sci
– volume: 172
  start-page: 731
  year: 2015
  end-page: 742
  ident: bib0132
  article-title: Pharmacological Management of Lewy Body Dementia: a Systematic Review and Meta-Analysis
  publication-title: Am J Psychiatry
– volume: 66
  start-page: 633
  year: 2005
  end-page: 637
  ident: bib0160
  article-title: Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias
  publication-title: J Clin Psychiatry
– volume: 9
  start-page: 7803
  year: 2019
  ident: bib0079
  article-title: Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease
  publication-title: Sci Rep
– volume: 24
  start-page: 360
  year: 2010
  end-page: 364
  ident: bib0167
  article-title: Treating neuropsychiatric symptoms in dementia with Lewy bodies: a randomized controlled-trial
  publication-title: Alzheimer Dis Assoc Disord
– volume: 65
  start-page: 1863
  year: 2005
  end-page: 1872
  ident: bib0090
  article-title: Diagnosis and management of dementia with Lewy bodies
  publication-title: Neurology
– volume: 22
  start-page: 1689
  year: 2007
  end-page: 1837
  ident: bib0004
  article-title: Clinical diagnostic criteria for dementia associated with Parkinson's disease
  publication-title: Mov Disord
– volume: 12
  start-page: 44
  year: 2020
  ident: bib0069
  article-title: Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies
  publication-title: Alzheimers Res Ther
– volume: 46
  start-page: 101
  year: 2008
  end-page: 106
  ident: bib0057
  article-title: Behavioral and psychological symptoms in dementia with Lewy-bodies (DLB): frequency and relationship with disease severity and motor impairment
  publication-title: Arch Gerontol Geriatr
– volume: 19
  start-page: 157
  year: 2020
  end-page: 169
  ident: bib0019
  article-title: New evidence on the management of Lewy body dementia
  publication-title: Lancet Neurol
– volume: 137
  start-page: 2493
  year: 2014
  end-page: 2508
  ident: bib0031
  article-title: Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease
  publication-title: Brain
– volume: 28
  start-page: 853
  year: 2016
  end-page: 861
  ident: bib0088
  article-title: Delirium superimposed on dementia: a survey of delirium specialists shows a lack of consensus in clinical practice and research studies
  publication-title: International Psychogeriatrics
– volume: 5
  start-page: 442
  year: 2015
  end-page: 449
  ident: bib0096
  article-title: Clinical and cognitive phenotype of mild cognitive impairment evolving to dementia with Lewy bodies
  publication-title: Dement Geriatr Cogn Dis Extra
– volume: 11
  start-page: 83
  year: 2019
  ident: bib0067
  article-title: Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
  publication-title: Alzheimers Res Ther
– volume: 22
  start-page: 249
  year: 2013
  end-page: 257
  ident: bib0028
  article-title: LRRK2 as a Potential genetic modifier of synucleinopathies: interlacing the two major genetic factors of Parkinson’s disease
  publication-title: Exp Neurobiol
– volume: 29
  start-page: 392
  year: 2014
  end-page: 398
  ident: bib0158
  article-title: Time until nursing home admission in people with mild dementia: comparison of dementia with Lewy bodies and Alzheimer's dementia
  publication-title: Int J Geriatr Psychiatry
– volume: 16
  start-page: 528
  year: 2001
  end-page: 536
  ident: bib0039
  article-title: A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia
  publication-title: Int J Geriatr Psychiatry
– volume: 8
  start-page: 289
  year: 2005
  end-page: 291
  ident: bib0149
  article-title: Blazquez-Menes B. Exacerbation of Lewy bodies dementia due to memantine
  publication-title: J Alzheimers Dis
– volume: 28
  start-page: 393
  year: 2018
  end-page: 416
  ident: bib0164
  article-title: Prevalence of Depression, Anxiety and PTSD in People with Dementia: a Systematic Review and Meta-Analysis
  publication-title: Neuropsychol Rev
– volume: 10
  start-page: 19
  year: 2018
  ident: bib0006
  article-title: Clinical prevalence of Lewy body dementia
  publication-title: Alzheimers Res Ther
– volume: 38
  start-page: 64
  year: 2020
  end-page: 76
  ident: bib0124
  article-title: Diagnostic imaging of dementia with Lewy bodies, frontotemporal lobar degeneration, and normal pressure hydrocephalus
  publication-title: Jpn J Radiol
– volume: 65
  start-page: 1232
  year: 2005
  end-page: 1238
  ident: bib0044
  article-title: Verbal and visuospatial deficits in dementia with Lewy bodies
  publication-title: Neurology
– volume: 14
  start-page: 450
  year: 2018
  end-page: 464
  ident: bib0020
  article-title: Oxidative stress and the amyloid beta peptide in Alzheimer's disease
  publication-title: Redox Biol
– volume: 44
  start-page: 673
  year: 2014
  end-page: 683
  ident: bib0084
  article-title: The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies
  publication-title: Psychol Med
– volume: 12
  start-page: 120
  year: 2020
  ident: bib0070
  article-title: Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer's disease and dementia with Lewy bodies from the prodromal stage
  publication-title: Alzheimers Res Ther
– volume: 8
  start-page: 444
  year: 2018
  ident: bib0099
  article-title: The contribution of tau, amyloid-beta and alpha-synuclein pathology to dementia in Lewy body disorders
  publication-title: J Alzheimers Dis Parkinsonism
– volume: 9
  start-page: 85
  year: 2009
  end-page: 90
  ident: bib0042
  article-title: Neuropsychological profile of dementia with Lewy bodies
  publication-title: Psychogeriatrics
– volume: 64
  start-page: 2069
  year: 2005
  end-page: 2073
  ident: bib0112
  article-title: Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both
  publication-title: Neurology
– reference: (accessed March 31, 2022)
– volume: 16
  start-page: 388
  year: 2010
  end-page: 392
  ident: bib0106
  article-title: Lewy body dementia: the caregiver experience of clinical care
  publication-title: Parkinsonism Relat Disord
– volume: 7
  start-page: 270
  year: 2011
  end-page: 279
  ident: bib0108
  article-title: The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  publication-title: Alzheimer's & Dementia
– volume: 44
  start-page: 673
  year: 2014
  end-page: 683
  ident: bib0005
  article-title: The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies [published correction appears in Psychol Med. 2014 Mar;44(4):684]
  publication-title: Psychol Med
– year: 2013
  ident: bib0092
  article-title: Amyloid PET imaging in Lewy body disorders
  publication-title: Am J Geriatr Psychiatry
– volume: 8
  start-page: 613
  year: 2009
  end-page: 618
  ident: bib0144
  article-title: Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
  publication-title: Lancet Neurol
– volume: 18
  start-page: 937
  year: 2003
  end-page: 941
  ident: bib0140
  article-title: Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia
  publication-title: Int J Geriatr Psychiatry
– volume: 13
  start-page: 163
  year: 2021
  ident: bib0076
  article-title: Meta-analysis of cerebrospinal fluid neuron-specific enolase levels in Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy
  publication-title: Alzheimers Res Ther
– volume: 55
  start-page: 1613
  year: 2000
  end-page: 1620
  ident: bib0116
  article-title: A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia
  publication-title: Neurology
– volume: 25
  start-page: S110
  year: 2010
  end-page: S116
  ident: bib0014
  article-title: Cognitive impairment and dementia in Parkinson's disease
  publication-title: Mov Disord
– volume: 18
  start-page: 988
  year: 2003
  end-page: 993
  ident: bib0139
  article-title: What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia
  publication-title: Int J Geriatr Psychiatry
– volume: 13
  year: 2021
  ident: bib0064
  article-title: Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies
  publication-title: Front Aging Neurosci
– volume: 32
  start-page: 202
  year: 2011
  end-page: 208
  ident: bib0085
  article-title: Early and presenting symptoms of dementia with Lewy bodies
  publication-title: Dement Geriatr Cogn Disord
– volume: 135
  start-page: 2458
  year: 2012
  end-page: 2469
  ident: bib0045
  article-title: Pareidolias: complex visual illusions in dementia with Lewy bodies
  publication-title: Brain
– volume: 10
  start-page: 1015
  year: 2020
  ident: bib0065
  article-title: A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies
  publication-title: Diagnostics (Basel)
– volume: 80
  start-page: 662
  year: 2016
  end-page: 673
  ident: bib0093
  article-title: Survival and dementia in GBA-associated Parkinson’s disease: the mutation matters
  publication-title: Ann Neurol
– volume: 43
  start-page: S83
  year: 2016
  end-page: S95
  ident: bib0013
  article-title: The Prevalence and incidence of Dementia with Lewy Bodies: a systematic review
  publication-title: Can J Neurol Sci
– volume: 7
  start-page: 5
  year: 2015
  ident: bib0137
  article-title: Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial
  publication-title: Alzheimers Res Ther
– volume: vol. 95
  start-page: e3257
  year: 2020
  end-page: e3268
  ident: bib0059
  article-title: β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies
  publication-title: Neurology
– volume: 84
  start-page: 1326
  year: 2013
  end-page: 1330
  ident: bib0118
  article-title: Early neuropsychological discriminants for Lewy body disease: an autopsy series
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 58
  start-page: 463
  year: 2017
  end-page: 470
  ident: bib0097
  article-title: Prodromal dementia with Lewy bodies and prodromal Alzheimer's disease: a comparison of the cognitive and clinical profiles
  publication-title: J Alzheimers Dis
– volume: 173
  start-page: 543
  year: 2016
  end-page: 546
  ident: bib0159
  article-title: The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia
  publication-title: Am J Psychiatry
– volume: 127
  start-page: 311
  year: 2020
  end-page: 322
  ident: bib0082
  article-title: High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases
  publication-title: J Neural Transm (Vienna)
– volume: 33
  start-page: 1724
  year: 2018
  end-page: 1733
  ident: bib0071
  article-title: α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with Lewy bodies [published correction appears in Mov Disord. 2019 Jan;34(1):159]
  publication-title: Mov Disord
– volume: 36
  start-page: 229
  year: 2013
  end-page: 241
  ident: bib0136
  article-title: Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study
  publication-title: Dement Geriatr Cogn Disord
– volume: 9
  year: 2014
  ident: bib0157
  article-title: Effective use of the built environment to manage behavioural and psychological symptoms of dementia: a systematic review
  publication-title: PLoS ONE
– volume: 18
  start-page: 50
  year: 2016
  ident: bib0172
  article-title: Treatment of REM sleep behavior disorder
  publication-title: Curr Treat Options Neurol
– volume: 30
  start-page: 314
  year: 2022
  end-page: 328
  ident: bib0177
  article-title: Long-term efficacy and safety of zonisamide for treatment of parkinsonism in patients with dementia with Lewy bodies: an open-label extension of a phase three randomized controlled trial
  publication-title: Am J Geriatr Psychiatry
– volume: 9
  start-page: 56
  year: 2009
  end-page: 61
  ident: bib0169
  article-title: Depression associated with dementia with Lewy bodies (dementia with Lewy bodies) and the effect of somatotherapy
  publication-title: Psychogeriatrics
– volume: 16
  start-page: 522
  year: 2010
  end-page: 526
  ident: bib0173
  article-title: Levodopa response in dementia with Lewy bodies: a 1-year follow-up study
  publication-title: Parkinsonism Relat Disord
– volume: 142
  start-page: 961
  year: 2021
  end-page: 984
  ident: bib0074
  article-title: Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders
  publication-title: Acta Neuropathol
– volume: 49
  start-page: 2342
  year: 2019
  end-page: 2353
  ident: bib0056
  article-title: Auditory and visual hallucination prevalence in Parkinson's disease and dementia with Lewy bodies: a systematic review and meta-analysis
  publication-title: Psychol Med
– volume: 7
  start-page: 4
  year: 2015
  ident: bib0135
  article-title: Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial
  publication-title: Alzheimers Res Ther
– volume: 74
  start-page: 310
  year: 2017
  end-page: 315
  ident: bib0018
  article-title: Duration and pathologic correlates of Lewy body disease
  publication-title: JAMA Neurol
– volume: 25
  start-page: 1030
  year: 2010
  end-page: 1038
  ident: bib0151
  article-title: The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia
  publication-title: Int J Geriatr Psychiatry
– volume: 22
  start-page: 80
  year: 2016
  end-page: 86
  ident: bib0054
  article-title: Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders
  publication-title: Parkinsonism Relat Disord
– volume: 34
  start-page: 421
  year: 2019
  end-page: 432
  ident: bib0066
  article-title: Cerebrospinal fluid, imaging, and physiological biomarkers in dementia with Lewy bodies
  publication-title: Am J Alzheimers Dis Other Demen
– volume: 153
  start-page: 433
  year: 2020
  end-page: 454
  ident: bib0027
  article-title: Synucleinopathies: where we are and where we need to go
  publication-title: J Neurochem
– volume: 16
  start-page: 34
  year: 2018
  ident: bib0037
  article-title: Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
  publication-title: BMC Med
– volume: 70
  start-page: 223
  year: 2013
  end-page: 228
  ident: bib0030
  article-title: APOE ε4 increases risk for dementia in pure synucleinopathies
  publication-title: JAMA Neurol
– volume: 140
  start-page: 3286
  year: 2017
  end-page: 3300
  ident: bib0111
  article-title: Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease
  publication-title: Brain
– reference: .
– volume: 72
  start-page: 41
  year: 2012
  end-page: 52
  ident: bib0134
  article-title: Donepezil-DLB Study Investigators. Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial
  publication-title: Ann Neurol
– volume: 6
  start-page: 400
  year: 2008
  end-page: 413
  ident: bib0104
  article-title: Diagnostic difficulty and error in primary care—a systematic review
  publication-title: Fam Pract
– volume: 257
  start-page: 359
  year: 2010
  end-page: 366
  ident: bib0107
  article-title: Low sensitivity in clinical diagnoses of dementia with Lewy bodies
  publication-title: J Neurol
– volume: 386
  start-page: 1683
  year: 2015
  end-page: 1697
  ident: bib0008
  article-title: Lewy body dementias
  publication-title: Lancet
– volume: 23
  start-page: 837
  year: 2008
  end-page: 844
  ident: bib0007
  article-title: The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years
  publication-title: Mov Disord
– volume: 38
  start-page: 937
  year: 2008
  end-page: 945
  ident: bib0141
  article-title: Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial)
  publication-title: Neurosci Behav Physiol
– volume: 53
  start-page: 291
  year: 2019
  end-page: 303
  ident: bib0156
  article-title: Dementia with Lewy bodies: challenges in the diagnosis and management
  publication-title: Austral New Zeal J Psychiatry
– volume: 11
  start-page: 1419
  year: 2021
  ident: bib0023
  article-title: Structural and functional insights into α-synuclein fibril polymorphism
  publication-title: Biomolecules
– volume: 73
  start-page: 1355
  year: 2020
  end-page: 1361
  ident: bib0077
  article-title: Chromogranin A analysis in the differential diagnosis across Lewy body disorders
  publication-title: J Alzheimers Dis
– volume: 51
  start-page: 1
  issue: 1
  year: 2013
  ident: 10.1016/j.disamonth.2022.101441_bib0022
  article-title: Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review
  publication-title: Folia Neuropathol
  doi: 10.5114/fn.2013.34190
– volume: 18
  start-page: S2
  issue: Suppl 6
  year: 2003
  ident: 10.1016/j.disamonth.2022.101441_bib0002
  article-title: Neuropathological spectrum of synucleinopathies
  publication-title: Mov Disord
  doi: 10.1002/mds.10557
– volume: 7
  start-page: e45451
  issue: 10
  year: 2012
  ident: 10.1016/j.disamonth.2022.101441_bib0053
  article-title: The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson’s disease with dementia
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0045451
– volume: 9
  start-page: 969
  issue: 10
  year: 2010
  ident: 10.1016/j.disamonth.2022.101441_bib0146
  article-title: Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(10)70194-0
– volume: 151
  start-page: 110
  issue: 1
  year: 2015
  ident: 10.1016/j.disamonth.2022.101441_bib0009
  article-title: Factores genéticos de la demencia en la enfermedad de Parkinson (EP) [Genetic factors associated with dementia in Parkinson's disease (PD)]
  publication-title: Gac Med Mex
– volume: 27
  start-page: 43
  issue: 1
  year: 2020
  ident: 10.1016/j.disamonth.2022.101441_bib0068
  article-title: The value of cerebrospinal fluid α-synuclein and the tau/α-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology
  publication-title: Eur J Neurol
  doi: 10.1111/ene.14032
– volume: 74
  start-page: 839
  issue: 7
  year: 2017
  ident: 10.1016/j.disamonth.2022.101441_bib0015
  article-title: Survival and causes of death among people with clinically diagnosed synucleinopathies with parkinsonism: a population-based study
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2017.0603
– volume: 21
  start-page: 303
  year: 2015
  ident: 10.1016/j.disamonth.2022.101441_bib0122
  article-title: High specificity of MMSE pentagon scoring for diagnosis of prodromal dementia with Lewy bodies
  publication-title: Parkinsonism and Related Disorders
  doi: 10.1016/j.parkreldis.2014.12.007
– volume: 8
  start-page: 613
  issue: 7
  year: 2009
  ident: 10.1016/j.disamonth.2022.101441_bib0144
  article-title: Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(09)70146-2
– volume: 70
  start-page: 727
  issue: 6
  year: 2013
  ident: 10.1016/j.disamonth.2022.101441_bib0010
  article-title: A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2013.1925
– volume: 7
  start-page: 4
  issue: 1
  year: 2015
  ident: 10.1016/j.disamonth.2022.101441_bib0135
  article-title: Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial
  publication-title: Alzheimers Res Ther
  doi: 10.1186/s13195-014-0083-0
– volume: 28
  start-page: 393
  issue: 4
  year: 2018
  ident: 10.1016/j.disamonth.2022.101441_bib0164
  article-title: Prevalence of Depression, Anxiety and PTSD in People with Dementia: a Systematic Review and Meta-Analysis
  publication-title: Neuropsychol Rev
  doi: 10.1007/s11065-018-9396-2
– volume: 23
  start-page: 373
  issue: 4
  year: 2015
  ident: 10.1016/j.disamonth.2022.101441_bib0152
  article-title: Memantine for Lewy body disorders: systematic review and meta-analysis
  publication-title: Am J Geriatr Psychiatry
  doi: 10.1016/j.jagp.2013.11.007
– volume: 7
  start-page: 270
  year: 2011
  ident: 10.1016/j.disamonth.2022.101441_bib0108
  article-title: The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  publication-title: Alzheimer's & Dementia
  doi: 10.1016/j.jalz.2011.03.008
– volume: 80
  start-page: 662
  year: 2016
  ident: 10.1016/j.disamonth.2022.101441_bib0093
  article-title: Survival and dementia in GBA-associated Parkinson’s disease: the mutation matters
  publication-title: Ann Neurol
  doi: 10.1002/ana.24777
– volume: 17
  start-page: 40
  issue: Suppl 1
  year: 2004
  ident: 10.1016/j.disamonth.2022.101441_bib0142
  article-title: Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 12-week interim analysis
  publication-title: Dement Geriatr Cogn Disord
  doi: 10.1159/000074681
– volume: 70
  start-page: 223
  issue: 2
  year: 2013
  ident: 10.1016/j.disamonth.2022.101441_bib0030
  article-title: APOE ε4 increases risk for dementia in pure synucleinopathies
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2013.600
– volume: 22
  start-page: 1689
  issue: 12
  year: 2007
  ident: 10.1016/j.disamonth.2022.101441_bib0004
  article-title: Clinical diagnostic criteria for dementia associated with Parkinson's disease
  publication-title: Mov Disord
  doi: 10.1002/mds.21507
– volume: 64
  start-page: 2069
  issue: 12
  year: 2005
  ident: 10.1016/j.disamonth.2022.101441_bib0112
  article-title: Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000165987.89198.65
– volume: 9
  start-page: 7803
  issue: 1
  year: 2019
  ident: 10.1016/j.disamonth.2022.101441_bib0079
  article-title: Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-44173-8
– volume: 30
  start-page: 395
  issue: 3
  year: 2018
  ident: 10.1016/j.disamonth.2022.101441_bib0154
  article-title: Systematic review of the efficacy of non-pharmacological interventions in people with Lewy body dementia
  publication-title: Int Psychogeriatr
  doi: 10.1017/S1041610217002010
– volume: 38
  start-page: 937
  issue: 9
  year: 2008
  ident: 10.1016/j.disamonth.2022.101441_bib0141
  article-title: Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial)
  publication-title: Neurosci Behav Physiol
  doi: 10.1007/s11055-008-9077-3
– volume: 1867
  start-page: 890
  issue: 10
  year: 2019
  ident: 10.1016/j.disamonth.2022.101441_bib0021
  article-title: α-Synuclein misfolding and aggregation: implications in Parkinson’s disease pathogenesis
  publication-title: Biochim Biophys Acta Proteins Proteom
  doi: 10.1016/j.bbapap.2019.03.001
– volume: 10
  start-page: 689
  issue: 5
  year: 2004
  ident: 10.1016/j.disamonth.2022.101441_bib0100
  article-title: A comparison of episodic memory deficits in neuropathologically-confirmed Dementia with Lewy bodies and Alzheimer's disease
  publication-title: J Int Neuropsychol Soc
  doi: 10.1017/S1355617704105043
– volume: 8
  start-page: 289
  issue: 3
  year: 2005
  ident: 10.1016/j.disamonth.2022.101441_bib0149
  article-title: Blazquez-Menes B. Exacerbation of Lewy bodies dementia due to memantine
  publication-title: J Alzheimers Dis
  doi: 10.3233/JAD-2005-8307
– volume: 10
  start-page: 19
  issue: 1
  year: 2018
  ident: 10.1016/j.disamonth.2022.101441_bib0006
  article-title: Clinical prevalence of Lewy body dementia
  publication-title: Alzheimers Res Ther
  doi: 10.1186/s13195-018-0350-6
– volume: 55
  start-page: 1613
  issue: 11
  year: 2000
  ident: 10.1016/j.disamonth.2022.101441_bib0116
  article-title: A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000434309.85312.19
– volume: 10
  start-page: 1177
  issue: 8
  year: 2020
  ident: 10.1016/j.disamonth.2022.101441_bib0063
  article-title: Contactin-1 is reduced in cerebrospinal fluid of Parkinson’s disease patients and is present within Lewy bodies
  publication-title: Biomolecules
  doi: 10.3390/biom10081177
– volume: 26
  start-page: 10
  issue: 1
  year: 2011
  ident: 10.1016/j.disamonth.2022.101441_bib0162
  article-title: Risk of cerebrovascular adverse events and death in elderly patients with dementia when treated with antipsychotic medications: a literature review of evidence
  publication-title: Am J Alzheimers Dis Other Demen
  doi: 10.1177/1533317510390351
– volume: 8
  start-page: 444
  year: 2018
  ident: 10.1016/j.disamonth.2022.101441_bib0099
  article-title: The contribution of tau, amyloid-beta and alpha-synuclein pathology to dementia in Lewy body disorders
  publication-title: J Alzheimers Dis Parkinsonism
  doi: 10.4172/2161-0460.1000444
– volume: 27
  start-page: 213
  year: 2013
  ident: 10.1016/j.disamonth.2022.101441_bib0121
  article-title: The Qualitative Scoring MMSE Pentagon Test (QSPT): a new method for differentiating dementia with Lewy Body from Alzheimer’s disease
  publication-title: Behav Neurol
  doi: 10.1155/2013/728158
– volume: 173
  start-page: 543
  issue: 5
  year: 2016
  ident: 10.1016/j.disamonth.2022.101441_bib0159
  article-title: The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2015.173501
– volume: 16
  start-page: 522
  issue: 8
  year: 2010
  ident: 10.1016/j.disamonth.2022.101441_bib0173
  article-title: Levodopa response in dementia with Lewy bodies: a 1-year follow-up study
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/j.parkreldis.2010.06.004
– volume: 89
  start-page: 88
  issue: 1
  year: 2017
  ident: 10.1016/j.disamonth.2022.101441_bib0003
  article-title: Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000004058
– volume: 18
  start-page: 50
  issue: 11
  year: 2016
  ident: 10.1016/j.disamonth.2022.101441_bib0172
  article-title: Treatment of REM sleep behavior disorder
  publication-title: Curr Treat Options Neurol
  doi: 10.1007/s11940-016-0433-2
– volume: 73
  start-page: 1355
  issue: 4
  year: 2020
  ident: 10.1016/j.disamonth.2022.101441_bib0077
  article-title: Chromogranin A analysis in the differential diagnosis across Lewy body disorders
  publication-title: J Alzheimers Dis
  doi: 10.3233/JAD-191153
– volume: 29
  start-page: 392
  issue: 4
  year: 2014
  ident: 10.1016/j.disamonth.2022.101441_bib0158
  article-title: Time until nursing home admission in people with mild dementia: comparison of dementia with Lewy bodies and Alzheimer's dementia
  publication-title: Int J Geriatr Psychiatry
  doi: 10.1002/gps.4015
– volume: 44
  start-page: 673
  issue: 4
  year: 2014
  ident: 10.1016/j.disamonth.2022.101441_bib0005
  article-title: The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies [published correction appears in Psychol Med. 2014 Mar;44(4):684]
  publication-title: Psychol Med
  doi: 10.1017/S0033291713000494
– volume: 153
  start-page: 433
  issue: 4
  year: 2020
  ident: 10.1016/j.disamonth.2022.101441_bib0027
  article-title: Synucleinopathies: where we are and where we need to go
  publication-title: J Neurochem
  doi: 10.1111/jnc.14965
– volume: 140
  start-page: 3286
  issue: 12
  year: 2017
  ident: 10.1016/j.disamonth.2022.101441_bib0111
  article-title: Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease
  publication-title: Brain
  doi: 10.1093/brain/awx243
– volume: 38
  start-page: 64
  issue: 1
  year: 2020
  ident: 10.1016/j.disamonth.2022.101441_bib0124
  article-title: Diagnostic imaging of dementia with Lewy bodies, frontotemporal lobar degeneration, and normal pressure hydrocephalus
  publication-title: Jpn J Radiol
  doi: 10.1007/s11604-019-00881-9
– volume: 22
  start-page: 713
  issue: 8
  year: 2007
  ident: 10.1016/j.disamonth.2022.101441_bib0001
  article-title: Patients with Lewy body dementia use more resources than those with Alzheimer's disease
  publication-title: Int J Geriatr Psychiatry
  doi: 10.1002/gps.1738
– volume: 266
  start-page: 1
  issue: 1
  year: 2019
  ident: 10.1016/j.disamonth.2022.101441_bib0128
  article-title: Neuroimaging in Lewy body dementia
  publication-title: J Neurol
  doi: 10.1007/s00415-018-8892-x
– volume: 32
  start-page: 786
  issue: 7
  year: 2017
  ident: 10.1016/j.disamonth.2022.101441_bib0038
  article-title: Cognitive and neuropsychiatric features in Parkinson's and Lewy Body Dementias
  publication-title: Arch Clin Neuropsychol
  doi: 10.1093/arclin/acx085
– volume: 257
  start-page: 359
  year: 2010
  ident: 10.1016/j.disamonth.2022.101441_bib0107
  article-title: Low sensitivity in clinical diagnoses of dementia with Lewy bodies
  publication-title: J Neurol
  doi: 10.1007/s00415-009-5324-y
– volume: 18
  start-page: 937
  issue: 10
  year: 2003
  ident: 10.1016/j.disamonth.2022.101441_bib0140
  article-title: Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia
  publication-title: Int J Geriatr Psychiatry
  doi: 10.1002/gps.949
– volume: 34
  start-page: 421
  issue: 7–8
  year: 2019
  ident: 10.1016/j.disamonth.2022.101441_bib0066
  article-title: Cerebrospinal fluid, imaging, and physiological biomarkers in dementia with Lewy bodies
  publication-title: Am J Alzheimers Dis Other Demen
  doi: 10.1177/1533317519869700
– volume: 53
  start-page: 695
  issue: 4
  year: 2005
  ident: 10.1016/j.disamonth.2022.101441_bib0115
  article-title: The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment [published correction appears in J Am Geriatr Soc. 2019 Sep;67(9):1991]
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.2005.53221.x
– volume: 14
  start-page: 450
  year: 2018
  ident: 10.1016/j.disamonth.2022.101441_bib0020
  article-title: Oxidative stress and the amyloid beta peptide in Alzheimer's disease
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2017.10.014
– volume: 22
  start-page: 249
  issue: 4
  year: 2013
  ident: 10.1016/j.disamonth.2022.101441_bib0028
  article-title: LRRK2 as a Potential genetic modifier of synucleinopathies: interlacing the two major genetic factors of Parkinson’s disease
  publication-title: Exp Neurobiol
  doi: 10.5607/en.2013.22.4.249
– volume: 18
  start-page: 988
  issue: 11
  year: 2003
  ident: 10.1016/j.disamonth.2022.101441_bib0139
  article-title: What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia
  publication-title: Int J Geriatr Psychiatry
  doi: 10.1002/gps.995
– volume: 15
  start-page: 1811
  year: 2021
  ident: 10.1016/j.disamonth.2022.101441_bib0176
  article-title: The application of zonisamide to patients suffering from dementia with Lewy bodies: emerging clinical data
  publication-title: Drug Des Devel Ther
  doi: 10.2147/DDDT.S240865
– volume: 29
  start-page: 254
  issue: 5
  year: 2016
  ident: 10.1016/j.disamonth.2022.101441_bib0125
  article-title: Imaging in dementia with Lewy bodies: an overview
  publication-title: J Geriatr Psychiatry Neurol
  doi: 10.1177/0891988716654984
– volume: 19
  start-page: 499
  year: 2018
  ident: 10.1016/j.disamonth.2022.101441_bib0163
  article-title: Pharmacological interventions for psychosis in Parkinson's disease patients
  publication-title: Expert Opin Pharmacother
  doi: 10.1080/14656566.2018.1445721
– volume: 135
  start-page: 2458
  issue: Pt 8
  year: 2012
  ident: 10.1016/j.disamonth.2022.101441_bib0045
  article-title: Pareidolias: complex visual illusions in dementia with Lewy bodies
  publication-title: Brain
  doi: 10.1093/brain/aws126
– volume: 32
  start-page: 202
  year: 2011
  ident: 10.1016/j.disamonth.2022.101441_bib0085
  article-title: Early and presenting symptoms of dementia with Lewy bodies
  publication-title: Dement Geriatr Cogn Disord
  doi: 10.1159/000333072
– volume: 4
  start-page: 735
  issue: 11
  year: 2005
  ident: 10.1016/j.disamonth.2022.101441_bib0050
  article-title: Behavioural changes and psychological symptoms in dementia disorders
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(05)70219-2
– volume: 45
  start-page: 635
  issue: 7
  year: 2019
  ident: 10.1016/j.disamonth.2022.101441_bib0033
  article-title: Review: clinical, neuropathological and genetic features of Lewy body dementias
  publication-title: Neuropathol Appl Neurobiol
  doi: 10.1111/nan.12554
– volume: 74
  start-page: 310
  issue: 3
  year: 2017
  ident: 10.1016/j.disamonth.2022.101441_bib0018
  article-title: Duration and pathologic correlates of Lewy body disease
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2016.4926
– volume: 62
  start-page: 1804
  issue: 10
  year: 2004
  ident: 10.1016/j.disamonth.2022.101441_bib0052
  article-title: Autonomic dysfunction in dementia with Lewy bodies
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000125192.69777.6D
– volume: 22
  start-page: 80
  year: 2016
  ident: 10.1016/j.disamonth.2022.101441_bib0054
  article-title: Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/j.parkreldis.2015.11.019
– volume: 5
  start-page: 442
  year: 2015
  ident: 10.1016/j.disamonth.2022.101441_bib0096
  article-title: Clinical and cognitive phenotype of mild cognitive impairment evolving to dementia with Lewy bodies
  publication-title: Dement Geriatr Cogn Dis Extra
  doi: 10.1159/000441184
– volume: 31
  start-page: 137
  issue: 2
  year: 2016
  ident: 10.1016/j.disamonth.2022.101441_bib0041
  article-title: Assessing fluctuating cognition in dementia diagnosis: interrater reliability of the clinician assessment of fluctuation
  publication-title: Am J Alzheimers Dis Other Demen
  doi: 10.1177/1533317515603359
– volume: 89
  start-page: 88
  year: 2017
  ident: 10.1016/j.disamonth.2022.101441_bib0083
  article-title: Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000004058
– volume: 75
  start-page: 382
  issue: 3
  year: 2004
  ident: 10.1016/j.disamonth.2022.101441_bib0095
  article-title: Fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease is qualitatively distinct
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.2002.002576
– volume: 19
  start-page: 1
  issue: 1
  year: 2013
  ident: 10.1016/j.disamonth.2022.101441_bib0127
  article-title: Polysomnographic findings in dementia with Lewy bodies
  publication-title: Neurologist
  doi: 10.1097/NRL.0b013e31827c6bdd
– volume: 86
  start-page: 135
  issue: 2
  year: 2015
  ident: 10.1016/j.disamonth.2022.101441_bib0133
  article-title: Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp-2014-307659
– volume: 21
  start-page: 61
  issue: 2
  year: 2018
  ident: 10.1016/j.disamonth.2022.101441_bib0123
  article-title: Clinical imaging in dementia with Lewy bodies
  publication-title: Evid Based Ment Health
  doi: 10.1136/eb-2017-102848
– volume: 33
  start-page: 1197
  issue: 5
  year: 2021
  ident: 10.1016/j.disamonth.2022.101441_bib0129
  article-title: Electroencephalogram in dementia with Lewy bodies: a systematic review
  publication-title: Aging Clin Exp Res
  doi: 10.1007/s40520-020-01576-2
– volume: 129
  start-page: 729
  issue: Pt 3
  year: 2006
  ident: 10.1016/j.disamonth.2022.101441_bib0101
  article-title: What best differentiates Lewy body from Alzheimer's disease in early-stage dementia?
  publication-title: Brain
  doi: 10.1093/brain/awh725
– volume: 38
  start-page: 163
  issue: 1
  year: 2017
  ident: 10.1016/j.disamonth.2022.101441_bib0171
  article-title: Prevalence of rapid eye movement sleep behavior disorder (RBD) in Parkinson's disease: a meta and meta-regression analysis
  publication-title: Neurol Sci
  doi: 10.1007/s10072-016-2744-1
– volume: 33
  start-page: 1724
  issue: 11
  year: 2018
  ident: 10.1016/j.disamonth.2022.101441_bib0071
  article-title: α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with Lewy bodies [published correction appears in Mov Disord. 2019 Jan;34(1):159]
  publication-title: Mov Disord
  doi: 10.1002/mds.111
– volume: 23
  start-page: 23
  year: 2015
  ident: 10.1016/j.disamonth.2022.101441_bib0098
  article-title: Amyloid PET Imaging in Lewy body disorders
  publication-title: Am J Geriatr Psychiatry
  doi: 10.1016/j.jagp.2013.03.001
– volume: 25
  start-page: 1
  issue: S1
  year: 2010
  ident: 10.1016/j.disamonth.2022.101441_bib0165
  article-title: P03-380-The efficacy of psychopharmacologic treatment in depressive disorder associated with Parkinson's disease dementia
  publication-title: European Psychiatry
  doi: 10.1016/S0924-9338(10)70986-X
– volume: 10
  start-page: 3
  issue: 1
  year: 2018
  ident: 10.1016/j.disamonth.2022.101441_bib0062
  article-title: The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias
  publication-title: Alzheimers Res Ther
  doi: 10.1186/s13195-017-0331-1
– volume: 43
  start-page: S83
  issue: Suppl 1
  year: 2016
  ident: 10.1016/j.disamonth.2022.101441_bib0013
  article-title: The Prevalence and incidence of Dementia with Lewy Bodies: a systematic review
  publication-title: Can J Neurol Sci
  doi: 10.1017/cjn.2016.2
– volume: 17
  start-page: 73
  issue: 10
  year: 2017
  ident: 10.1016/j.disamonth.2022.101441_bib0126
  article-title: Molecular imaging and updated diagnostic criteria in Lewy body dementias
  publication-title: Curr Neurol Neurosci Rep
  doi: 10.1007/s11910-017-0789-z
– volume: 22
  start-page: 1689
  year: 2007
  ident: 10.1016/j.disamonth.2022.101441_bib0089
  article-title: Clinical diagnostic criteria for dementia associated with Parkinson's disease
  publication-title: Mov Disord
  doi: 10.1002/mds.21507
– volume: 200
  start-page: 37
  year: 2012
  ident: 10.1016/j.disamonth.2022.101441_bib0086
  article-title: Features of subsyndromal and persistent delirium
  publication-title: The British Journal of Psychiatry
  doi: 10.1192/bjp.bp.111.095273
– volume: 24
  start-page: 1405
  issue: 12
  year: 2009
  ident: 10.1016/j.disamonth.2022.101441_bib0011
  article-title: Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests
  publication-title: Int J Geriatr Psychiatry
  doi: 10.1002/gps.2277
– volume: 135
  start-page: 3005
  issue: Pt 10
  year: 2012
  ident: 10.1016/j.disamonth.2022.101441_bib0110
  article-title: Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies
  publication-title: Brain
  doi: 10.1093/brain/aws234
– volume: 9
  issue: 12
  year: 2014
  ident: 10.1016/j.disamonth.2022.101441_bib0157
  article-title: Effective use of the built environment to manage behavioural and psychological symptoms of dementia: a systematic review
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0115425
– volume: 9
  start-page: 85
  issue: 2
  year: 2009
  ident: 10.1016/j.disamonth.2022.101441_bib0042
  article-title: Neuropsychological profile of dementia with Lewy bodies
  publication-title: Psychogeriatrics
  doi: 10.1111/j.1479-8301.2009.00283.x
– volume: 137
  start-page: 2493
  issue: Pt 9
  year: 2014
  ident: 10.1016/j.disamonth.2022.101441_bib0031
  article-title: Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease
  publication-title: Brain
  doi: 10.1093/brain/awu193
– volume: 24
  start-page: 1446
  issue: 12
  year: 2017
  ident: 10.1016/j.disamonth.2022.101441_bib0170
  article-title: Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis
  publication-title: Eur J Neurol
  doi: 10.1111/ene.13449
– volume: 172
  start-page: 731
  issue: 8
  year: 2015
  ident: 10.1016/j.disamonth.2022.101441_bib0132
  article-title: Pharmacological Management of Lewy Body Dementia: a Systematic Review and Meta-Analysis
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2015.14121582
– volume: 48
  start-page: 1749
  issue: 11
  year: 2018
  ident: 10.1016/j.disamonth.2022.101441_bib0155
  article-title: Non-pharmacological interventions for Lewy body dementia: a systematic review
  publication-title: Psychol Med
  doi: 10.1017/S0033291717003257
– volume: 47
  start-page: e10
  issue: 2
  year: 2013
  ident: 10.1016/j.disamonth.2022.101441_bib0147
  article-title: Blaszczyk AT. Visual hallucinations treated with the reinitiation of memantine in a patient with Lewy body dementia
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1R522
– volume: 1765
  year: 2021
  ident: 10.1016/j.disamonth.2022.101441_bib0081
  article-title: Serum tyrosine is associated with better cognition in Lewy body dementia
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2021.147481
– volume: 30
  start-page: 46
  issue: 1
  year: 2015
  ident: 10.1016/j.disamonth.2022.101441_bib0145
  article-title: Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies
  publication-title: Int J Geriatr Psychiatry
  doi: 10.1002/gps.4109
– ident: 10.1016/j.disamonth.2022.101441_bib0138
– volume: 18
  start-page: 12
  year: 2017
  ident: 10.1016/j.disamonth.2022.101441_bib0087
  article-title: The diagnosis of delirium superimposed on dementia: an emerging challenge
  publication-title: J Am Med Dir Assoc
  doi: 10.1016/j.jamda.2016.07.014
– volume: 44
  start-page: 673
  issue: 4
  year: 2014
  ident: 10.1016/j.disamonth.2022.101441_bib0084
  article-title: The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies
  publication-title: Psychol Med
  doi: 10.1017/S0033291713000494
– volume: 6
  start-page: 400
  year: 2008
  ident: 10.1016/j.disamonth.2022.101441_bib0104
  article-title: Diagnostic difficulty and error in primary care—a systematic review
  publication-title: Fam Pract
  doi: 10.1093/fampra/cmn071
– volume: 5
  start-page: 442
  year: 2015
  ident: 10.1016/j.disamonth.2022.101441_bib0120
  article-title: Clinical and cognitive phenotype of mild cognitive impairment evolving to dementia with Lewy Bodies
  publication-title: Dement Geriatr Cogn Disord
  doi: 10.1159/000441184
– volume: 79
  start-page: 17m11623
  issue: 3
  year: 2018
  ident: 10.1016/j.disamonth.2022.101441_bib0055
  article-title: Clinical features of auditory hallucinations in patients with dementia with Lewy bodies: a soundtrack of visual hallucinations
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.17m11623
– volume: 46
  start-page: 101
  issue: 1
  year: 2008
  ident: 10.1016/j.disamonth.2022.101441_bib0057
  article-title: Behavioral and psychological symptoms in dementia with Lewy-bodies (DLB): frequency and relationship with disease severity and motor impairment
  publication-title: Arch Gerontol Geriatr
  doi: 10.1016/j.archger.2007.03.003
– volume: 34
  start-page: 1069
  issue: 7
  year: 2019
  ident: 10.1016/j.disamonth.2022.101441_bib0075
  article-title: Dementia with Lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile
  publication-title: Mov Disord
  doi: 10.1002/mds.27731
– volume: vol. 95
  start-page: e3257
  issue: 24
  year: 2020
  ident: 10.1016/j.disamonth.2022.101441_bib0059
  article-title: β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000010943
– volume: 37
  start-page: 57
  issue: 1
  year: 2016
  ident: 10.1016/j.disamonth.2022.101441_bib0043
  article-title: Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials
  publication-title: Neurol Sci
  doi: 10.1007/s10072-015-2357-0
– volume: 32
  start-page: 1280
  year: 2017
  ident: 10.1016/j.disamonth.2022.101441_bib0105
  article-title: Development of assessment toolkits for improving the diagnosis of the Lewy body dementias: feasibility study within the DIAMOND Lewy study
  publication-title: Int J Geriatr Psychiatry
  doi: 10.1002/gps.4609
– volume: 73
  start-page: 535
  year: 2016
  ident: 10.1016/j.disamonth.2022.101441_bib0161
  article-title: Association of antipsychotic use with mortality risk in patients with Parkinson disease
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2016.0031
– volume: 20
  start-page: 4674
  issue: 19
  year: 2019
  ident: 10.1016/j.disamonth.2022.101441_bib0078
  article-title: VGF Peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms20194674
– ident: 10.1016/j.disamonth.2022.101441_bib0080
  doi: 10.1136/jnnp-2021-327788
– volume: 17
  start-page: 32
  issue: 1
  year: 2011
  ident: 10.1016/j.disamonth.2022.101441_bib0025
  article-title: Parkinson's disease dementia and potential therapeutic strategies
  publication-title: CNS Neurosci Ther
  doi: 10.1111/j.1755-5949.2010.00216.x
– volume: 140
  start-page: 49
  year: 2020
  ident: 10.1016/j.disamonth.2022.101441_bib0072
  article-title: Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-020-02160-8
– volume: 65
  start-page: 481
  issue: 3
  year: 2005
  ident: 10.1016/j.disamonth.2022.101441_bib0150
  article-title: Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000172351.95783.8e
– volume: 13
  start-page: 217
  issue: 4
  year: 2017
  ident: 10.1016/j.disamonth.2022.101441_bib0016
  article-title: Cognitive decline in Parkinson disease
  publication-title: Nat Rev Neurol
  doi: 10.1038/nrneurol.2017.27
– volume: 65
  start-page: 1863
  year: 2005
  ident: 10.1016/j.disamonth.2022.101441_bib0090
  article-title: Diagnosis and management of dementia with Lewy bodies
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000187889.17253.b1
– volume: 13
  start-page: 163
  issue: 1
  year: 2021
  ident: 10.1016/j.disamonth.2022.101441_bib0076
  article-title: Meta-analysis of cerebrospinal fluid neuron-specific enolase levels in Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy
  publication-title: Alzheimers Res Ther
  doi: 10.1186/s13195-021-00907-3
– volume: 127
  start-page: 311
  issue: 3
  year: 2020
  ident: 10.1016/j.disamonth.2022.101441_bib0082
  article-title: High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases
  publication-title: J Neural Transm (Vienna)
  doi: 10.1007/s00702-019-02137-2
– volume: 64
  start-page: 416
  issue: 3
  year: 2007
  ident: 10.1016/j.disamonth.2022.101441_bib0109
  article-title: Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study
  publication-title: Arch Neurol
  doi: 10.1001/archneur.64.3.416
– volume: 36
  start-page: 707
  issue: 8
  year: 2007
  ident: 10.1016/j.disamonth.2022.101441_bib0148
  article-title: Memantine-induced decompensation in a patient with Lewy body dementia
  publication-title: Ann Acad Med Singap
  doi: 10.47102/annals-acadmedsg.V36N8p707
– volume: 19
  start-page: 157
  issue: 2
  year: 2020
  ident: 10.1016/j.disamonth.2022.101441_bib0019
  article-title: New evidence on the management of Lewy body dementia
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(19)30153-X
– volume: 43
  start-page: 583
  issue: 5
  year: 2007
  ident: 10.1016/j.disamonth.2022.101441_bib0117
  article-title: A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer's disease and Parkinson's disease with dementia
  publication-title: Cortex
  doi: 10.1016/S0010-9452(08)70489-1
– volume: 16
  start-page: 388
  year: 2010
  ident: 10.1016/j.disamonth.2022.101441_bib0106
  article-title: Lewy body dementia: the caregiver experience of clinical care
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/j.parkreldis.2010.03.007
– volume: 4
  start-page: 428
  issue: 6
  year: 2007
  ident: 10.1016/j.disamonth.2022.101441_bib0017
  article-title: Predictors of survival in dementia with Lewy bodies and Parkinson dementia
  publication-title: Neurodegener Dis
  doi: 10.1159/000107703
– volume: 35
  start-page: 55
  issue: 1
  year: 2021
  ident: 10.1016/j.disamonth.2022.101441_bib0060
  article-title: Biomarker use for dementia with Lewy body diagnosis: survey of US experts
  publication-title: Alzheimer Dis Assoc Disord
  doi: 10.1097/WAD.0000000000000414
– volume: 72
  start-page: 41
  issue: 1
  year: 2012
  ident: 10.1016/j.disamonth.2022.101441_bib0134
  article-title: Donepezil-DLB Study Investigators. Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial
  publication-title: Ann Neurol
  doi: 10.1002/ana.23557
– volume: 12
  start-page: 189
  issue: 3
  year: 1975
  ident: 10.1016/j.disamonth.2022.101441_bib0114
  article-title: "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician
  publication-title: J Psychiatr Res
  doi: 10.1016/0022-3956(75)90026-6
– volume: 12
  start-page: 44
  issue: 1
  year: 2020
  ident: 10.1016/j.disamonth.2022.101441_bib0069
  article-title: Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies
  publication-title: Alzheimers Res Ther
  doi: 10.1186/s13195-020-00610-9
– volume: 32
  start-page: 202
  issue: 3
  year: 2011
  ident: 10.1016/j.disamonth.2022.101441_bib0035
  article-title: Early and presenting symptoms of dementia with Lewy bodies
  publication-title: Dement Geriatr Cogn Disord
  doi: 10.1159/000333072
– volume: 36
  start-page: 229
  issue: 3–4
  year: 2013
  ident: 10.1016/j.disamonth.2022.101441_bib0136
  article-title: Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study
  publication-title: Dement Geriatr Cogn Disord
  doi: 10.1159/000351672
– volume: 25
  start-page: 1030
  issue: 10
  year: 2010
  ident: 10.1016/j.disamonth.2022.101441_bib0151
  article-title: The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia
  publication-title: Int J Geriatr Psychiatry
  doi: 10.1002/gps.2506
– volume: 9
  start-page: 62
  issue: 1
  year: 2021
  ident: 10.1016/j.disamonth.2022.101441_bib0073
  article-title: Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies
  publication-title: Acta Neuropathol Commun
  doi: 10.1186/s40478-021-01175-w
– volume: 65
  start-page: 1232
  issue: 8
  year: 2005
  ident: 10.1016/j.disamonth.2022.101441_bib0044
  article-title: Verbal and visuospatial deficits in dementia with Lewy bodies
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000180964.60708.c2
– volume: 14
  start-page: 29
  issue: 1
  year: 2019
  ident: 10.1016/j.disamonth.2022.101441_bib0024
  article-title: Alpha-synuclein structure and Parkinson's disease - lessons and emerging principles
  publication-title: Mol Neurodegener
  doi: 10.1186/s13024-019-0329-1
– volume: 14
  start-page: 626
  issue: 9
  year: 2013
  ident: 10.1016/j.disamonth.2022.101441_bib0032
  article-title: Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn3549
– volume: 23
  start-page: 837
  issue: 6
  year: 2008
  ident: 10.1016/j.disamonth.2022.101441_bib0007
  article-title: The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years
  publication-title: Mov Disord
  doi: 10.1002/mds.21956
– volume: 28
  start-page: 1416
  issue: 10
  year: 2013
  ident: 10.1016/j.disamonth.2022.101441_bib0049
  article-title: Analysis of video-polysomnographic sleep findings in dementia with Lewy bodies
  publication-title: Mov Disord
  doi: 10.1002/mds.25523
– volume: 58
  start-page: 463
  year: 2017
  ident: 10.1016/j.disamonth.2022.101441_bib0097
  article-title: Prodromal dementia with Lewy bodies and prodromal Alzheimer's disease: a comparison of the cognitive and clinical profiles
  publication-title: J Alzheimers Dis
  doi: 10.3233/JAD-161089
– volume: 386
  start-page: 1683
  issue: 10004
  year: 2015
  ident: 10.1016/j.disamonth.2022.101441_bib0008
  article-title: Lewy body dementias
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)00462-6
– volume: 110
  start-page: 24
  issue: 7
  year: 2010
  ident: 10.1016/j.disamonth.2022.101441_bib0174
  publication-title: Zh Nevrol Psikhiatr Im S S Korsakova
– volume: 28
  start-page: 853
  year: 2016
  ident: 10.1016/j.disamonth.2022.101441_bib0088
  article-title: Delirium superimposed on dementia: a survey of delirium specialists shows a lack of consensus in clinical practice and research studies
  publication-title: International Psychogeriatrics
  doi: 10.1017/S1041610215002288
– volume: 12
  start-page: 120
  issue: 1
  year: 2020
  ident: 10.1016/j.disamonth.2022.101441_bib0070
  article-title: Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer's disease and dementia with Lewy bodies from the prodromal stage
  publication-title: Alzheimers Res Ther
  doi: 10.1186/s13195-020-00684-5
– volume: 10
  start-page: 1015
  issue: 12
  year: 2020
  ident: 10.1016/j.disamonth.2022.101441_bib0065
  article-title: A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies
  publication-title: Diagnostics (Basel)
  doi: 10.3390/diagnostics10121015
– volume: 88
  start-page: 503
  issue: 3
  year: 2020
  ident: 10.1016/j.disamonth.2022.101441_bib0061
  article-title: Alpha-synuclein oligomers and neurofilament light chain in spinal fluid differentiate multiple system atrophy from Lewy body synucleinopathies
  publication-title: Ann Neurol
  doi: 10.1002/ana.25824
– volume: 28
  start-page: 1095
  issue: 10
  year: 2013
  ident: 10.1016/j.disamonth.2022.101441_bib0168
  article-title: Modafinil and armodafinil improve attention and global mental status in Lewy bodies disorders: preliminary evidence
  publication-title: Int J Geriatr Psychiatry
  doi: 10.1002/gps.3952
– volume: 12
  start-page: 46
  issue: 1
  year: 2020
  ident: 10.1016/j.disamonth.2022.101441_bib0130
  article-title: EEG alpha reactivity and cholinergic system integrity in Lewy body dementia and Alzheimer's disease
  publication-title: Alzheimers Res Ther
  doi: 10.1186/s13195-020-00613-6
– volume: 34
  start-page: 603
  issue: 4
  year: 2018
  ident: 10.1016/j.disamonth.2022.101441_bib0012
  article-title: Lewy Body Dementia
  publication-title: Clin Geriatr Med
  doi: 10.1016/j.cger.2018.06.007
– volume: 76
  start-page: 91
  year: 2020
  ident: 10.1016/j.disamonth.2022.101441_bib0178
  article-title: Effect of zonisamide on parkinsonism in patients with dementia with Lewy bodies: a phase 3 randomized clinical trial
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/j.parkreldis.2019.12.005
– volume: 32
  start-page: 857
  year: 2011
  ident: 10.1016/j.disamonth.2022.101441_bib0091
  article-title: Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?
  publication-title: Neurobiol Aging
  doi: 10.1016/j.neurobiolaging.2009.05.019
– volume: 79
  start-page: 627
  issue: 2
  year: 2021
  ident: 10.1016/j.disamonth.2022.101441_bib0046
  article-title: Efficacy and safety of zonisamide in dementia with Lewy bodies patients with Parkinsonism: a post hoc analysis of two randomized, double-blind, placebo-controlled trials
  publication-title: J Alzheimers Dis
  doi: 10.3233/JAD-200893
– volume: 142
  start-page: 961
  issue: 6
  year: 2021
  ident: 10.1016/j.disamonth.2022.101441_bib0074
  article-title: Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-021-02367-3
– volume: 24
  start-page: 360
  issue: 4
  year: 2010
  ident: 10.1016/j.disamonth.2022.101441_bib0167
  article-title: Treating neuropsychiatric symptoms in dementia with Lewy bodies: a randomized controlled-trial
  publication-title: Alzheimer Dis Assoc Disord
  doi: 10.1097/WAD.0b013e3181e6a4d7
– year: 2013
  ident: 10.1016/j.disamonth.2022.101441_bib0092
  article-title: Amyloid PET imaging in Lewy body disorders
  publication-title: Am J Geriatr Psychiatry
– volume: 25
  start-page: S110
  issue: Suppl 1
  year: 2010
  ident: 10.1016/j.disamonth.2022.101441_bib0014
  article-title: Cognitive impairment and dementia in Parkinson's disease
  publication-title: Mov Disord
– volume: 11
  start-page: 1419
  issue: 10
  year: 2021
  ident: 10.1016/j.disamonth.2022.101441_bib0023
  article-title: Structural and functional insights into α-synuclein fibril polymorphism
  publication-title: Biomolecules
  doi: 10.3390/biom11101419
– volume: 13
  year: 2021
  ident: 10.1016/j.disamonth.2022.101441_bib0064
  article-title: Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies
  publication-title: Front Aging Neurosci
  doi: 10.3389/fnagi.2021.717930
– volume: 12
  start-page: 182
  issue: 2
  year: 2012
  ident: 10.1016/j.disamonth.2022.101441_bib0048
  article-title: REM sleep behavior disorder and REM sleep without atonia as an early manifestation of degenerative neurological disease [published correction appears in Curr Neurol Neurosci Rep. 2012 Apr;12(2):226]
  publication-title: Curr Neurol Neurosci Rep
  doi: 10.1007/s11910-012-0253-z
– volume: 63
  start-page: 1450
  issue: 10
  year: 2006
  ident: 10.1016/j.disamonth.2022.101441_bib0102
  article-title: The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease
  publication-title: Arch Neurol
  doi: 10.1001/archneur.63.10.1450
– volume: 23
  start-page: 401
  issue: 6
  year: 2007
  ident: 10.1016/j.disamonth.2022.101441_bib0143
  article-title: Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study
  publication-title: Dement Geriatr Cogn Disord
  doi: 10.1159/000101512
– volume: 20
  start-page: 623
  issue: 4
  year: 2006
  ident: 10.1016/j.disamonth.2022.101441_bib0094
  article-title: Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease
  publication-title: Clin Neuropsychol
  doi: 10.1080/13854040500376831
– start-page: 1
  year: 2022
  ident: 10.1016/j.disamonth.2022.101441_bib0131
  article-title: Systematic review of pharmacological interventions for people with Lewy body dementia [published online ahead of print, 2022 Feb 2]
  publication-title: Aging Ment Health
– volume: 66
  start-page: 633
  issue: 5
  year: 2005
  ident: 10.1016/j.disamonth.2022.101441_bib0160
  article-title: Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.v66n0514
– volume: 9
  start-page: 56
  year: 2009
  ident: 10.1016/j.disamonth.2022.101441_bib0169
  article-title: Depression associated with dementia with Lewy bodies (dementia with Lewy bodies) and the effect of somatotherapy
  publication-title: Psychogeriatrics
  doi: 10.1111/j.1479-8301.2009.00292.x
– volume: 7
  start-page: 45
  issue: 1
  year: 2015
  ident: 10.1016/j.disamonth.2022.101441_bib0047
  article-title: Comprehensive treatment of dementia with Lewy bodies
  publication-title: Alzheimers Res Ther
  doi: 10.1186/s13195-015-0128-z
– volume: 49
  start-page: 2342
  issue: 14
  year: 2019
  ident: 10.1016/j.disamonth.2022.101441_bib0056
  article-title: Auditory and visual hallucination prevalence in Parkinson's disease and dementia with Lewy bodies: a systematic review and meta-analysis
  publication-title: Psychol Med
  doi: 10.1017/S0033291718003161
– volume: 16
  start-page: 528
  issue: 5
  year: 2001
  ident: 10.1016/j.disamonth.2022.101441_bib0039
  article-title: A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia
  publication-title: Int J Geriatr Psychiatry
  doi: 10.1002/gps.389
– volume: 53
  start-page: 291
  issue: 4
  year: 2019
  ident: 10.1016/j.disamonth.2022.101441_bib0156
  article-title: Dementia with Lewy bodies: challenges in the diagnosis and management
  publication-title: Austral New Zeal J Psychiatry
  doi: 10.1177/0004867419835029
– volume: 16
  start-page: 34
  issue: 1
  year: 2018
  ident: 10.1016/j.disamonth.2022.101441_bib0037
  article-title: Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
  publication-title: BMC Med
  doi: 10.1186/s12916-018-1016-8
– volume: 27
  start-page: 1
  issue: 1
  year: 2017
  ident: 10.1016/j.disamonth.2022.101441_bib0113
  article-title: The Differential Effects of Alzheimer's Disease and Lewy Body Pathology on Cognitive Performance: a Meta-analysis
  publication-title: Neuropsychol Rev
  doi: 10.1007/s11065-016-9334-0
– volume: 7
  start-page: 5
  issue: 1
  year: 2015
  ident: 10.1016/j.disamonth.2022.101441_bib0137
  article-title: Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial
  publication-title: Alzheimers Res Ther
  doi: 10.1186/s13195-014-0081-2
– volume: 22
  start-page: 435
  issue: 2 Dementia
  year: 2016
  ident: 10.1016/j.disamonth.2022.101441_bib0026
  article-title: Lewy Body dementias: dementia With Lewy bodies and Parkinson disease dementia
  publication-title: Continuum (Minneap Minn)
  doi: 10.1212/CON.0000000000000309
– volume: 30
  start-page: 314
  issue: 3
  year: 2022
  ident: 10.1016/j.disamonth.2022.101441_bib0177
  article-title: Long-term efficacy and safety of zonisamide for treatment of parkinsonism in patients with dementia with Lewy bodies: an open-label extension of a phase three randomized controlled trial
  publication-title: Am J Geriatr Psychiatry
  doi: 10.1016/j.jagp.2021.07.002
– volume: 11
  start-page: 83
  issue: 1
  year: 2019
  ident: 10.1016/j.disamonth.2022.101441_bib0067
  article-title: Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
  publication-title: Alzheimers Res Ther
  doi: 10.1186/s13195-019-0537-5
– volume: 11
  start-page: 94
  issue: 7
  year: 2021
  ident: 10.1016/j.disamonth.2022.101441_bib0040
  article-title: Lewy body dementias: a coin with two sides?
  publication-title: Behav Sci (Basel)
  doi: 10.3390/bs11070094
– volume: 4
  issue: 7
  year: 2014
  ident: 10.1016/j.disamonth.2022.101441_bib0153
  article-title: Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson’s disease with dementia: a prospective study
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2014-005158
– volume: 84
  start-page: 1326
  issue: 12
  year: 2013
  ident: 10.1016/j.disamonth.2022.101441_bib0118
  article-title: Early neuropsychological discriminants for Lewy body disease: an autopsy series
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp-2012-304381
– volume: 33
  start-page: 629
  issue: 3
  year: 2012
  ident: 10.1016/j.disamonth.2022.101441_bib0029
  article-title: DLB and PDD: a role for mutations in dementia and Parkinson disease genes?
  publication-title: Neurobiol Aging
  doi: 10.1016/j.neurobiolaging.2011.10.014
– volume: 44
  start-page: 673
  year: 2014
  ident: 10.1016/j.disamonth.2022.101441_bib0103
  article-title: The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies
  publication-title: Psychol Med
  doi: 10.1017/S0033291713000494
– volume: 18
  start-page: 591
  issue: 4
  year: 2022
  ident: 10.1016/j.disamonth.2022.101441_bib0036
  article-title: The temporal onset of the core features in dementia with Lewy bodies
  publication-title: Alzheimers Dement
  doi: 10.1002/alz.12411
– volume: 33
  start-page: 528
  issue: 4
  year: 2018
  ident: 10.1016/j.disamonth.2022.101441_bib0034
  article-title: Biomarkers for cognitive impairment in Lewy body disorders: status and relevance for clinical trials
  publication-title: Mov Disord
  doi: 10.1002/mds.27355
– volume: 495
  start-page: 318
  year: 2019
  ident: 10.1016/j.disamonth.2022.101441_bib0058
  article-title: Parkinson's and Lewy body dementia CSF biomarkers
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cca.2019.04.078
– volume: 25
  start-page: 601
  issue: 5
  year: 2013
  ident: 10.1016/j.disamonth.2022.101441_bib0175
  article-title: Rotigotine for anxiety during wearing-off in Parkinson's disease with dementia
  publication-title: Aging Clin Exp Res
  doi: 10.1007/s40520-013-0136-4
– volume: 65
  start-page: 16
  issue: Suppl 11
  year: 2004
  ident: 10.1016/j.disamonth.2022.101441_bib0051
  article-title: Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms
  publication-title: J Clin Psychiatry
– volume: 6
  start-page: 53
  issue: 5–8
  year: 2014
  ident: 10.1016/j.disamonth.2022.101441_bib0119
  article-title: A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer's disease
  publication-title: Alzheimers Res Ther
SSID ssj0012950
Score 2.4326904
SecondaryResourceType review_article
Snippet Lewy Body Dementia is the second most frequent neurodegenerative illness proven to cause dementia, after Alzheimer's disease (AD). It is believed to be vastly...
AbstractLewy Body Dementia is the second most frequent neurodegenerative illness proven to cause dementia, after Alzheimer's disease (AD). It is believed to be...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 101441
SubjectTerms Alzheimer Disease - diagnosis
Alzheimer Disease - etiology
Alzheimer Disease - therapy
Dementia - diagnosis
Dementia - etiology
Dementia - therapy
Dementia with Lewy bodies
Diagnosis, Differential
Humans
Internal Medicine
Lewy body dementia
Lewy Body Disease - complications
Lewy Body Disease - diagnosis
Lewy Body Disease - therapy
Parkinson Disease - complications
Parkinson disease dementia
Synucleinopathies
Title Recent advances in Lewy body dementia: A comprehensive review
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0011502922001250
https://www.clinicalkey.es/playcontent/1-s2.0-S0011502922001250
https://dx.doi.org/10.1016/j.disamonth.2022.101441
https://www.ncbi.nlm.nih.gov/pubmed/35690493
https://www.proquest.com/docview/2675602168
Volume 69
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEB5CCiGXkubRbtoGBXJ1Ymn1sBZ6WJaEbV6nBHITsixTh-AN8YaSS397R7ZsCGlIoEcLDzLDPL7xfCMBHHBaipylIpHauoRLmieaa59wVWQCY3I2di3b4lLOr_npjbhZgVk_CxNolTH2dzG9jdZx5Shq8-i-qsKMb0AzTLNAC2Jt3c65CrZ--GegeWA6E90YCqVJePsZx6uomnCnzzJ0JRgLq5zT1zLUawi0zUQnG_AxQkgy7b7yE6z4ehPWLmKTfAt-IBTEVEJie78hVU3O_e8nki-KJ1K0_wMrOyFTEvjkD_5Xx2En3RTLNlyfHF_N5km8JSFx6D9LhMe5ptaKUnHBXKZTX-ZY71qFxQJPC6qUKyyVCAzRVREOyNJpjyBBohQvbD7egdV6UfsvQJT11GvpcptlnDuppbKlwxJLqNIisBqB7DVjXDxCPNxkcWd6rtitGVRqgkpNp9IRpIPgfXeKxtsiWa960w-JYlgzGOnfFlX_EvVNdM_GUNMwk5oXJjSCySD5zArft-1-byEGfTQ0XmztF4-NYViVSQRTMhvB5850BjWMhdRYpY13_2frr7COT5GI-Q1Wlw-P_juCpWW-13rDHnyY_jybX_4FMQcRJw
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS91AEB9Eoe1FtK31qbUr9BrN7tuPrOBBRHltn54UvC2bzYZGJE_ME_Hi3-5ssgmIFQteNxk2DPPxm-xvdgB-clqKnKUikdq6hEuaJ5prn3BVZAJjcjZ2LdviTE4u-O9LcbkAR30vTKBVxtjfxfQ2WseVvajNvZuqCj2-Ac0wzQItiIW6fYmHMQdo1LuPA88D85no-lAoTcLrz0heRdWEoT7zcCzBWFjlnL6Wol6DoG0qOlmB5YghyWH3mauw4OvP8OE0npJ_gQPEgphLSDzfb0hVk6m_fyD5rHggRftDsLL75JAEQvmt_9uR2EnXxvIVLk6Oz48mSRyTkDh0oDni41xTa0WpuGAu06kvcyx4rcJqgacFVcoVlkpEhuiriAdk6bRHlCBRihc2H6_BYj2r_ToQZT31WrrcZhnnTmqpbOmwxhKqtIisRiB7zRgX7xAPoyyuTU8WuzKDSk1QqelUOoJ0ELzprtF4WyTrVW_6LlGMawZD_dui6l-ivon-2RhqGmZS88KGRrA_SD4zw__bdqe3EINOGk5ebO1nd41hWJZJRFMyG8G3znQGNYyF1FimjTfes_UP-Dg5P52a6a-zP5vwCZ9EVuYWLM5v7_x3RE7zfLv1jCc7thKw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recent+advances+in+Lewy+body+dementia%3A+A+comprehensive+review&rft.jtitle=Disease-a-month&rft.au=Prasad%2C+Sakshi&rft.au=Katta%2C+Maanya+Rajasree&rft.au=Abhishek%2C+Shuchi&rft.au=Sridhar%2C+Rishala&rft.date=2023-05-01&rft.issn=1557-8194&rft.eissn=1557-8194&rft.volume=69&rft.issue=5&rft.spage=101441&rft_id=info:doi/10.1016%2Fj.disamonth.2022.101441&rft.externalDBID=NO_FULL_TEXT
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00115029%2FS0011502923X00054%2Fcov150h.gif